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INTRODUCTION 
 
Cardiovascular diseases (CVDs) have now become the leading cause of 
mortality in India. A quarter of all mortality is attributable to cardiovascular 
diseases. Ischemic heart disease and stroke are the predominant causes and are 
responsible for >80% of cardiovascular disease deaths. 
Recent reports of 3 large prospective studies from India suggest a higher 
proportion of mortality attributable to cardiovascular disease (30%–42%) and an 
age-standardized cardiovascular disease mortality rate (255–525 per 100000 
populations in men and 225–299 per 100000 populations in women) in 
comparison with the Global Burden of Disease study. Thus cardiovascular 
disease has emerged as the leading cause of death in all parts of India, including 
poorer states and rural areas. 
Countering the epidemic, requires the development of strategies such as 
the formulation and effective implementation of evidence based policy and 
reinforcement of health systems. Emphasis on prevention requires methods for 
early detection. Treatment requires the use of both conventional and innovative 
techniques. 
There are many risk factors for cardiovascular disease and some can be 
controlled but not others. The risk factors that can be controlled (modifiable) are: 
High blood pressure; high blood cholesterol levels; smoking; diabetes; 
overweight or obesity; lack of physical activity; unhealthy diet and stress. The 
importance of controlling blood pressure was finally embraced in practice 
guidelines in the first “Report of the Joint National Committee (JNC) on 
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Detection, Evaluation, and Treatment of High Blood Pressure” in 1977. It is now 
recognized universally that hypertension increases atherosclerotic cardiovascular 
disease incidence; the risk burden is 2–3-fold. Hypertension predisposes to all 
clinical manifestations of coronary heart disease including myocardial infarction, 
angina pectoris, and sudden death. Hence early detection of hypertension by 
routine clinical measurement of blood pressure becomes essential in the 
prevention of cardiovascular diseases. 
In the measurement of blood pressure, the difference in blood pressure 
between arms was first described in 1900.Since 2001–2002, it was hypothesized 
that Interarm difference of blood pressure was associated with peripheral 
arterial disease and then reported the first prospective association of interarm 
difference of blood pressure with increased mortality. Since then, numerous 
studies have been done demonstrating the association of interarm difference of 
blood pressure wih cardiovascular mortality. 
Studies also show that increase in Carotid intima media thickness 
(CIMT) is associated with increase in the risk of stroke and may help refine risk 
prediction. Since 2000, 7 guidelines or consensus statements have recommended 
measuring carotid intima media thickness and/or carotid plaque detection as 
clinical tools to assist with cardiovascular disease risk prediction. 
The Atherosclerosis Risk in Communities (ARIC) study measured carotid 
intima media thickness and observed that extreme mean carotid intima media 
thickness > 1 mm, when compared to mean carotid intima media thickness                  
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< 1mm, was associated with an increased incidence of cardiovascular disease for 
both women and men. 
In a new cross- sectional study of 1426 patients, Ma and colleagues have 
carefully examined the association of interarm systolic blood pressure difference 
(IASBPD) with carotid intima media thickness. They calculated maximum and 
average intima media thickness over 36 carotid sites, avoiding plaque, and 
achieved excellent interobserver agreement. 
The prevalence of interarm systolic blood pressure varies from 1.9% to 
19% as per systemic review and meta analysis of 16 studies. S.-J. Park et al. 
identifies interarm systolic blood pressure difference as a significant factor 
associated with the Gensini score, not only in hypertensive patients, but also in 
prehypertensive patients. 
Hence a study is undertaken in our Institution to know the correlation 
between inter arm systolic blood pressure difference and carotid intima media 
thickness in patients with coronary artery disease and stroke. This cost effective 
technique of recording of interarm systolic blood pressure difference in 
hypertensive patients will help to identify individuals at greater risk of 
cardiovascular diseases at an early stage  even at the level of primary health care 
system. 
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AIM AND OBJECTIVES 
 
 
1. To record the interarm systolic blood pressure difference in                 
hypertensive patients   with coronary artery disease and stroke. 
2. To measure carotid intima media thickness in above patients by Carotid 
Doppler ultrasound. 
3. To find out the correlation between interarm systolic blood pressure 
difference and carotid intima media thickness in above group. 
4. To recommend the recording of interarm systolic blood pressure 
difference in hypertensive patients as a routine for identification of 
patients at risk of cardiovascular diseases at an early stage. 
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REVIEW OF LITERATURE 
 
HISTORICAL ASPECTS 
The modern history of hypertension begins with the understanding of the 
cardiovascular system based on the work of physician William Harvey (1578–
1657).The concept of hypertensive disease as a generalized circulatory disease 
was taken up by Sir Clifford Allbutt. However hypertension as a medical entity 
really came into being in 1896 with the invention of the cuff-based 
sphygmomanometer by Scipione Riva-Rocci in 1896.The term essential 
hypertension  was coined by Eberhard Frank in 1911 to describe elevated 
blood pressure for which no cause could be found. 
Nikolai N. Anichkov (1885–1964) first demonstrated the role of 
cholesterol in the development of atherosclerosis. In 1856, Rudolph Virchow 
proposed that the lesions of atherosclerosis result from injury to the artery 
wall. 
The  inter-arm  difference in  blood pressure has  received  attention  
globally was  discovered  by  Osler  in  1915  who  noted first. The  term  inter 
arm difference  was  secondly  recognized  more than  95  years  ago  and  
employed  in  the  year 1920  by  Cyriax. 
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B-mode ultrasound measurements of the carotid intima-media thickness 
(CIMT) have been first described in 1986 by Pignoli et al. in an in vitro study of 
common carotid arteries. In 1991, Salonen and colleagues showed for the first 
time the in vivo use of ultrasound imaging for the evaluation of atherosclerotic 
changes in the carotid arteries. 
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INTRODUCTION 
HYPERTENSION 
Hypertension affects millions of people. It is estimated that by 2025, 
1.56 billion adults will be living with hypertension .The overall occurrence is 
similar between both men and women, but differs with age. Blood pressure 
values increase with age  and is very common with the elderly. In adults less 
than 45 years, hypertension is more common in men and above 65 years it 
affects women more than men. 
This disease is sometimes called the "silent killer." Because it is usually 
asymptomatic until the damaging effects of hypertension (such as stroke, 
myocardial infarction, renal dysfunction, visual problems, etc.) are observed. 
Hypertension is a major risk factor for atherosclerotic cardiovascular disease and 
an important contributor to coronary events, heart failure, stroke and end-stage 
kidney disease. 
BLOOD PRESSURE 
Lateral pressure exerted by column of blood on the walls of blood vessels 
while flowing through it. 
SYSTOLIC PRESSURE 
The maximal arterial pressure during systole is called systolic blood 
pressure and occurs during ventricular ejection. It is a function of cardiac output. 
Normal systolic pressure is 90-119 mmHg. 
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DIASTOLIC PRESSURE 
The minimal arterial pressure during diastole is called diastolic blood 
pressure and occurs just before the onset of ventricular ejection. Normal diastolic 
pressure is 60-79 mmHg. 
PULSE PRESSURE 
The difference between the systolic and diastolic blood pressures is the 
Pulse pressure. It ranges between 40 and 50 mmHg. High pulse pressure is 
indicative of systolic hypertension and indirectly determines decrease in 
elasticity of blood vessels. 
MEAN ARTERIAL PRESSURE 
It is the average blood pressure throughout the cardiac cycle, which 
determines the pressure head. 
Mean Arterial Pressure = Diastolic blood pressure + 1/ 3 Pulse pressure 
Normal Mean arterial pressure   is 93mm / Hg (range: 90-100mm / Hg). 
Regional blood flow through an organ depends on it. 
DEFINITION OF HYPERTENSION (CURRENT GUIDELINES) 
When the arterial pressure is ≥120/80 mmHg, a person is said to have 
"elevated" pressure or hypertension. 
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American Heart Association and the American College of Cardiology 
published new guidelines in November 2017 for defining and treating 
hypertension. Based upon large-scale clinical studies, the following definitions 
are now applied to adults: The current guidelines lower the threshold for Stage 1 
hypertension by 10 mmHg compared to JNC 7 & 8, which is a significant 
reduction.            
 
 
  
 
 
 
 
  
             
           
 
 
 
 
 
 
 
Blood Pressure Categories in Adults (Current Guidelines) 
Category 
SystolicBP 
   (mmHg) 
 
DiastolicBP  
(mmHg) 
Normal < 120 And < 80 
Elevated 120 – 129 And < 80 
Hypertension    
Stage 1 130 – 139 Or 80 – 89 
Stage 2 ≥140 Or ≥ 90 
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RISKFACTORS FOR HYPERTENSION  
NONMODIFIABLE 
RISK  FACTORS 
MODIFIABLE RISK FACTORS 
1.Ethnicity 
 
2.Increased age (>35 years) 
 
3.Family history of hypertension 
 
1.Overweight or obesity 
 
2.Smoking 
 
3.High intake of dietary sodium 
 
4.Excessive use of alcohol 
 
5.Sedentary lifestyle 
 
6.High level of stress 
 
7.Poorly controlled Diabetes 
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BASIC PRINCIPLES OF BLOOD PRESSURE REGULATION 
The major function of BP is to provide the driving force that moves blood 
through the vascular system to supply the needs of the tissues. Consequently, BP 
regulation is a complex physiologic function that depends on integrated actions 
of multiple cardiovascular, renal, neural, endocrine, and local tissue control 
systems. Hypertension is usually considered to be a disorder of the average level 
at which BP is regulated during resting conditions. The multiple local, hormonal, 
neural, and renal systems regulate BP by their influence on cardiac pumping or 
vascular resistance because mean arterial pressure is a product of  cardiac output 
and total peripheral resistance. 
FEEDBACK CONTROL SYSTEMS FOR BLOOD PRESSURE 
SHORT TERM REGULATION 
Three important neural control systems begin to function powerfully 
within seconds 
1. ARTERIAL BARORECEPTORS 
(In the pressure range of 180 – 200 mm/Hg) 
Arterial baroreceptor reflex is mediated by stretch-sensitive sensory nerve 
endings in the carotid sinuses and the aortic arch.  The rate of firing of these 
baroreceptors increases with arterial pressure, and the net effect is a decrease in 
sympathetic outflow, resulting in decreases in arterial pressure and heart rate. 
This is a primary mechanism for rapid buffering of acute fluctuations  of  arterial  
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pressure  that  may  occur  during  postural  changes,  behavioral  or  physiologic  
stress,  and changes in blood volume. They detect changes in BP and send 
appropriate autonomic reflex signals back to the heart and blood vessels to return 
the BP towards normal. 
Although the arterial baroreceptors clearly provide a powerful means for 
acute BP regulation, their role in long-term BP regulation is controversial. Some 
studies suggest that the baroreceptors reset within a few days to the level of BP 
to which they are exposed and are reset to higher BP in chronic hypertension. 
Other experimental studies, suggest that the baroreceptors do not completely 
reset and may contribute to chronic BP regulation. With prolonged increases in 
BP, the baroreceptor reflexes may contribute to reductions in renal sympathetic 
activity and promote sodium and water excretion, attenuating the increase in BP. 
Thus, impairment of baroreceptor reflexes may cause increased liability of 
BP in hypertension and may fail to attenuate the increase in BP caused by other 
disturbances. 
2. CHEMORECEPTORS 
(In the pressure range of 40 – 80 mm/Hg) 
They are located in the carotid and aortic bodies and respond to following 
changes in the blood 
1. Oxygen lack 
2. Carbon dioxide excess 
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3. Hydrogen ion excess. 
They initiate autonomic feedback responses that influence BP. 
3. CENTRAL NERVOUS  SYSTEM (CNS) ISCHEMIC   RESPONSE 
It responds within a few seconds to ischemia of the vasomotor center in 
the medulla, especially when BP falls below about 50 mm Hg. The carbon 
dioxide and lactic acid accumulated due to ischemia stimulate the neurons of 
vasomotor centre. 
Excitation of vasomotor centre causes strong sympathetic stimulation 
leading to vasoconstriction and immediate increase in blood pressure. Each of 
these nervous control mechanisms works rapidly and can have potent effects on 
BP. Also note, however, that the feedback gains of these systems decreases with 
time, as a disturbance of BP is maintained. 
INTERMEDIATE REGULATION 
Within a few minutes or hours after a BP disturbance, additional controls 
react, including 
1) CAPILLARY FLUID SHIFT MECHANISM 
A shift of fluid from the interstitial spaces into the blood in response to 
decreased BP or a shift of fluid out of the blood into the interstitial spaces in 
response to increased BP. 
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2) STRESS RELAXATION AND REVERSE STRESS RELAXATION 
When BP is high in the vessels, the vessels become stretched and 
continued to stretch for minutes or hours. This causes relaxation of blood vessels 
by vascular tone adjustment.  When BP is low in the vessels, there occurs 
tightening of vessels   by vascular tone adjustment. 
3)  RENIN ANGIOTENSIN ALDOSTERONE SYSTEM (RAAS) 
When there is fall in BP, this system is activated and suppressed when BP 
increases above normal. This system is explained in detail in long term 
regulation of BP. 
LONG-TERM BLOOD PRESSURE REGULATION 
1. RENAL–BODY FLUID FEEDBACK MECHANISM  
Pressure natriuresis and diuresis. 
Extracellular fluid volume is determined by the balance between intake 
and excretion of salt and water by the kidneys.  During steady-state conditions, 
there must be balance between intake and output of salt and water. Pressure 
natriuresis and diuresis is a key mechanism for regulating salt and water balance. 
Under most conditions, this mechanism stabilizes BP and body fluid volumes. 
When BP increases above the renal set point, because of increased total 
peripheral resistance or increased cardiac pumping, this also increases sodium 
and water excretion via pressure natriuresis and diuresis. Extracellular fluid 
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volume continues to decrease, reducing venous return and cardiac output until 
BP returns to normal and fluid balance is reestablished. 
An important feature of pressure natriuresis is that hormonal and neural 
control systems can amplify or attenuate the basic effects of BP on sodium and 
water excretion. Another important feature is that it continues to operate until BP 
returns to nearly the original set point. 
2. THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (RAAS) 
The renin-angiotensin-aldosterone system (RAAS) plays an important 
role in regulating blood volume and systemic vascular resistance, which together 
influence cardiac output and arterial pressure. As the name implies, there are 
three important components to this system: 1) renin, 2) angiotensin, and 3) 
aldosterone. Renin, which is released primarily by the kidneys, stimulates the 
formation of angiotensin in blood and tissues, which in turn stimulates the 
release of aldosterone from the adrenal cortex.Renin is a proteolytic enzyme that 
is released into the circulation by the kidneys. Its release is stimulated by: 
 Sympathetic nerve activation (acting through β1-adrenoceptors) 
 Renal artery hypotension (caused by systemic hypotension or renal artery  
stenosis) 
 Decreased sodium delivery to the distal tubules of the kidney. 
Juxtaglomerular (JG) cells associated with the afferent arteriole are the 
primary site of renin storage and release. A reduction in afferent arteriole 
pressure causes the release of renin from the juxtaglomerular cells, whereas 
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increased pressure inhibits renin release. Beta1-adrenoceptors located on the 
juxtaglomerular cells respond to sympathetic nerve stimulation by releasing 
renin. Specialized cells (macula densa) of distal tubules lie adjacent to the 
juxtaglomerular cells of the afferent arteriole. The macula densa senses the 
concentration of sodium and chloride ions in the tubular fluid. 
When sodium chloride (Nacl) is elevated in the tubular fluid, renin release 
is inhibited. In contrast, a reduction in tubular sodium chloride stimulates renin 
release by the juxtaglomerular cells. When afferent arteriole pressure is reduced, 
glomerular filtration decreases, and this reduces sodium chloride in the distal 
tubule. This serves as an important mechanism contributing to the release of 
renin when there is afferent arteriole hypotension, which can be caused by 
systemic hypotension or narrowing (stenosis) of the renal artery that supplies 
blood flow to the kidney. 
When renin is released into the blood, it acts upon a circulating substrate, 
angiotensinogen, that undergoes proteolytic cleavage to form the decapeptide 
angiotensin I. Vascular endothelium, particularly in the lungs, has an enzyme, 
angiotensin converting enzyme (ACE), that cleaves off two amino acids to 
form the octapeptide, angiotensin II (AII), although many other tissues in the 
body (heart, brain, vascular) also can form angiotensin II. 
Angiotensin II 
Vasoconstrictor effect 
It is a powerful vasoconstrictor. Angiotensin II–mediated constriction of 
efferent arterioles reduces renal blood flow and peritubular capillary hydrostatic 
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pressure and increases peritubular colloid osmotic pressure as a result of 
increased filtration fraction.  These changes, in turn, increase the driving force 
for fluid reabsorption across tubular epithelial cells. Reductions in renal 
medullary blood flow caused by efferent arteriolar constriction or by direct 
effects of angiotensin II on the vasa recta may also enhance reabsorption in the 
loop of Henle and collecting ducts. 
In most physiologic conditions, the constriction is confined mainly to the 
postglomerular efferent arterioles. The weak constrictor action of angiotensin II 
on preglomerular vessels is related, in part, to selective protection of these 
vessels by autacoid mechanisms such as prostaglandins (PGs) or endothelial-
derived Nitric oxide. 
Angiotensin II Stimulates Renal Sodium Reabsorption 
Physiologic activation of the Renin-angiotensin-aldosterone system 
usually occurs as compensation for conditions that cause volume depletion or 
under perfusion of the kidneys, such as sodium depletion, hemorrhage or heart 
failure. 
Increased angiotensin II formation helps restore renal perfusion by 
causing salt and water retention, which helps prevent reductions in blood 
pressure. It causes salt and water retention by increasing renal sodium 
reabsorption through stimulation of aldosterone secretion, by direct effects on 
epithelial transport and by hemodynamic effects. 
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Direct stimulation of tubular sodium reabsorption by angiotensin II occurs 
at low angiotensin II concentrations and is mediated in by actions on the luminal 
and basolateral membranes. In the proximal tubules, angiotensin II stimulates 
Na+ H+ exchanger on the luminal membrane and increases sodium-potassium 
ATPase activity as well as sodium bicarbonate cotransport on the basolateral 
membrane. These effects are partly mediated by inhibition of adenyl cyclase and 
increased phospholipase C activity. 
Sodium reabsorption in the loop of Henle, macula densa, and distal 
nephron segments is also stimulated by angiotensin II. At physiologic 
concentrations, angiotensin II increases bicarbonate reabsorption in the loop of 
Henle and stimulates Na+ K+ 2Cl- transport in the medullary thick ascending loop 
of Henle. Angiotensin II stimulates multiple ion transporters in the distal parts of 
the nephron as well as epithelial sodium channel activity in the cortical collecting 
ducts. 
Other actions of angiotensin II 
1. Acts on the adrenal cortex to release aldosterone, which in turn acts on the 
kidneys to increase sodium and fluid retention. 
2. Stimulates the release of vasopressin (antidiuretic hormone, ADH) from 
the posterior pituitary, which increases fluid retention by the kidneys. 
3. Stimulates thirst centers within the brain 
4. Facilitates norepinephrine release from sympathetic nerve endings and 
inhibits norepinephrine re-uptake by nerve endings, thereby enhancing   
sympathetic adrenergic function. 
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5. Stimulates cardiac hypertrophy and vascular hypertrophy 
ALDOSTERONE 
The primary mineralocorticoid in humans is a powerful sodium-retaining 
hormone and has important effects on renal-pressure natriuresis and blood 
pressure regulation. The primary sites of actions of aldosterone on sodium 
reabsorption are the principal cells of the distal tubules, cortical collecting 
tubules, and collecting ducts where aldosterone stimulates sodium reabsorption 
and potassium secretion. 
Aldosterone binds to intracellular mineralocorticoid receptors (MRs) and 
activates transcription by target genes, which in turn, stimulate synthesis or 
activation of the Na+ K+ ATPase pump on the basolateral epithelial membrane 
and activation of amiloride-sensitive sodium channels on the luminal side of the 
epithelial membrane. These effects are termed genomic because they are 
mediated by activation of gene transcription and require 60 to 90 minutes to 
occur after aldosterone administration. 
Aldosterone may also exert rapid nongenomic effects on the 
cardiovascular and renal systems. Aldosterone increases the sodium current in 
principal cells of the cortical collecting tubule through activation of the 
amiloride-sensitive sodium channel and stimulates the Na+-H+ exchanger in a 
few minutes after application. In vascular smooth muscle cells, aldosterone 
stimulates sodium influx by activating Na+-H+ exchanger in less than 4 minutes. 
The renin-angiotensin-aldosterone pathway is not only regulated by the 
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mechanisms that stimulate renin release, but it is also modulated by natriuretic 
peptides released by the heart. These natriuretic peptides act as an important 
counter-regulatory system. 
HUMORAL MECHANISMS 
There are several very important humoral mechanisms including 
1. Circulating catecholamines 
2. Renin-angiotensin system 
3. Vasopressin (antidiuretic hormone) 
4. Atrial natriuretic peptide 
5. Endothelin. 
Each of these humoral systems directly or indirectly alter cardiac function, 
vascular function, and arterial pressure. 
Circulating Catecholamines 
Circulating catecholamines, epinephrine and norepinephrine, originate 
from two sources. Epinephrine is released by the adrenal medulla upon activation 
of preganglionic sympathetic nerves innervating this tissue. This activation 
occurs during times of stress (e.g., exercise, heart failure, hemorrhage, emotional 
stress or excitement, pain). Norepinephrine is also released by the adrenal 
medulla (about 20% of its total catecholamine release is norepinephrine). The 
primary source of circulating norepinephrine is spillover from sympathetic 
nerves innervating blood vessels. 
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Normally, most of the norepinephrine released by sympathetic nerves is 
taken back up by the nerves (some is also taken up by extra-neuronal tissues) 
where it is metabolized. A small amount of norepinephrine, however, diffuses 
into the blood and circulates throughout the body. At times of high sympathetic 
nerve activation, the amount of norepinephrine entering the blood increases 
dramatically. There is also a specific adrenal medullary disorder (chromaffin cell 
tumor) that causes very high circulating levels of catecholamine. This can lead to 
a hypertensive crisis. 
Circulating epinephrine causes: 
•   Increased heart rate and inotropy (ß1-adrenoceptor mediated) 
•   Vasoconstriction in most systemic arteries and veins 
•  Vasodilation in muscle and liver vasculatures at low concentrations 
•   Vasoconstriction at high concentrations 
The overall cardiovascular response to low-to-moderate circulating 
concentrations of epinephrine is increased cardiac output and a redistribution of 
the cardiac output to muscular and hepatic circulations with only a small change 
in mean arterial pressure. Although cardiac output is increased, arterial pressure 
does not change much because the systemic vascular resistance falls due to α 2-
adrenoceptor activation. At high plasma concentrations, epinephrine increases 
arterial pressure because of binding to adrenoceptors on blood vessels, which 
offsets the  α 2-adrenoceptor mediated vasodilation. 
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Circulating norepinephrine causes: 
• Increased heart rate (although only transiently) and increased inotropy 
are the direct effects norepinephrine on the heart. 
• Vasoconstriction occurs in most systemic arteries and veins 
The overall cardiovascular response is increased cardiac output and 
systemic vascular resistance, which results in an elevation in arterial blood 
pressure. Heart rate, although initially stimulated by norepinephrine, decreases 
due to activation of baroreceptors and vagal mediated slowing of the heart rate. 
Atrial Natriuretic Peptide 
Atrial natriuretic peptide (ANP, ANF) is a 28 amino acid peptide that is 
synthesized, stored, and released by atrial myocytes in response to atrial 
distension, angiotensin II, endothelin, and sympathetic stimulation. 
Therefore, elevated levels of atrial natriuretic peptide are found during 
hypervolemic states (elevated blood volume) and congestive heart failure. Atrial 
natriuretic peptide is involved in the long-term regulation of sodium and water 
balance, blood volume and arterial pressure. This hormone decreases aldosterone 
release by the adrenal cortex, increases glomerular filtration rate (GFR), 
produces natriuresis and diuresis (potassium sparing), and decreases renin release 
thereby decreasing angiotensin II. These actions contribute to reductions in blood 
volume and therefore central venous pressure (CVP), cardiac output, and arterial 
blood pressure. Chronic elevations of atrial natriuretic peptide appear to decrease 
arterial blood pressure primarily by decreasing systemic vascular resistance. The 
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mechanism of systemic vasodilation may involve atrial natriuretic peptide 
receptor-mediated elevations in vascular smooth muscle cyclicGMP as well as 
by attenuating sympathetic vascular tone. This latter mechanism may involve 
atrial natriuretic peptide acting upon sites within the central nervous system as 
well as through inhibition of norepinephrine release by sympathetic nerve 
terminals. Therefore, atrial natriuretic peptide is a counter-regulatory system for 
the renin angiotensin-aldosterone system. 
TYPES OF HYPERTENSION 
1. Primary hypertension or Essential hypertension 
2. Secondary hypertension 
ETIOLOGY AND PATHOGENESIS 
 Hypertension is a disorder of BP regulation that results from an increase 
in cardiac output or an increase in total peripheral vascular resistance 
.PRIMARY HYPERTENSION 
 Approximately 90-95% of patients diagnosed with hypertension have 
primary hypertension. This form of high blood pressure tends to develop 
gradually over many years. Unlike secondary hypertension, there is no known 
cause of primary hypertension. 
Factors Influencing the Development of Primary Hypertension: 
1. Family history of hypertension 
2. Overweight 
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3. Alcohol consumption 
4. Excess Consumption of Sodium Chloride 
Certain segments of the population are salt sensitive because their blood 
pressure is affected by salt consumption 
5.  Lack of Exercise activity 
Less active individuals are 30-50% more likely to develop                        
hypertension. Approximately 40–60% is explained by genetic factors. Important 
environmental factors include a high salt intake, heavy consumption of alcohol, 
obesity, lack of exercise and impaired intra uterine growth.  There is little 
evidence that ‘stress’ causes hypertension. 
MECHANISMS OF PRIMARY HYPERTENSION: 
1. Increased activity of renin-angiotensin-aldosterone system 
 
 MECHANISMS OF PRIMARY HYPERTENSION 
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2- Hyperfunction of Sympathetic System 
1. Primary increased activity of vasomotor neurons 
2. Angiotensin-II and endothelin increases activity of vasomotor neurons 
3. Norepinephrine potentiates renin release. 
3. Vasoactive substance: Endothelial dysfunction: Releasing of vasoactive 
agents like endothelin will increases blood pressure. 
4. Renal defect to excrete sodium: Retention of sodium and water will lead to 
hypertension 
5. Insulin Resistance 
                     Insulin Resistance                     Hyperinsulinemia 
 
 
      Increased sympathetic      Sodium retention      arteriolar hypertrophy 
activity      
 
                                                                        Hypertension 
 
HEMODYNAMIC SUBTYPES OF PRIMARY HYPERTENSION 
Primary hypertension falls into three distinctly different hemodynamic 
subtypes that vary sharply by age. 
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Systolic Hypertension in Teenagers and Young Adults 
Typically associated with hypertension in the elderly, isolated systolic 
hypertension (ISH) also is the main type in young adults (typically 17 to 25 years 
of age). The key hemodynamic abnormalities are increased cardiac output and a 
stiff aorta, both presumably reflecting an overactive sympathetic nervous system. 
The prevalence may  reach  as  high  as  25%  in  young  men,  but  the  
condition  affects only  2%  of  young  women.  Several recent studies show that 
young persons  with  isolated systolic hypertension  have  elevated  central  as  
well  as  brachial  systolic blood  pressures,  indicating  significantly  increased  
hemodynamic burden. Thus isolated systolic hypertension in youth may 
predispose to diastolic hypertension in middle age. 
Diastolic Hypertension in Middle Age 
Hypertension diagnosed in middle age (typically 30 to 50 years of age) 
usually has the elevated diastolic pressure pattern, with normal systolic pressure 
(isolated diastolic hypertension) or elevated systolic pressure (combined systolic 
and diastolic hypertension). This pattern constitutes classic “essential 
hypertension.” Isolated diastolic hypertension is more common in men and often 
associates with middle age weight gain. 
Without treatment, isolated diastolic hypertension often progresses to 
combined systolic-diastolic hypertension. The fundamental  hemodynamic fault  
is an  elevated  systemic  vascular resistance  coupled  with  an  inappropriately 
normal  cardiac  output. Vasoconstriction at the level of the resistance arterioles 
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results from increased neurohormonal drive and an autoregulatory reaction of 
vascular smooth muscle to an expanded plasma volume, the latter because of 
impairment in the kidney’s ability to excrete sodium. 
Isolated Systolic Hypertension in Older Adults 
After the age of 55 years, Isolated systolic hypertension (systolic blood 
pressure >140 mm Hg and diastolic blood pressure < 90 mm Hg) predominates.  
In developed countries, systolic pressure rises steadily with age; by contrast, 
diastolic pressure rises until approximately 55 years of age and then falls 
progressively thereafter. The resultant widening of pulse pressure indicates 
stiffening of the central aorta and a more rapid return of reflected pulse waves 
from the periphery, augmenting systolic aortic pressure. Accumulation of 
collagen (which is poorly distensible) adversely affects its ratio to elastin in the 
aortic wall. 
Isolated systolic hypertension may represent an exaggeration of this age-
dependent stiffening process, although systolic blood pressure and pulse pressure 
do not rise with age in the absence of urbanization. Isolated systolic hypertension 
is more common in women and associates prominently with heart failure with 
preserved systolic function. 
In an elderly patient with isolated systolic hypertension and stiff arteries, 
pulse wave velocity is 12 meters/sec, which is abnormally fast.  The reflected 
pulse wave reaches the central aorta in systole, thereby amplifying central 
systolic pressure and widening the central pulse pressure. The augmented aortic 
SECONDARY HYPERTENSION 
 
Renal artery stenosis 
 
 
 
Primary hyperaldosteronism 
 
 
 
 
 
 
 
 
 
 
 
28 
 
systolic pressure accelerates the development of Left ventricular hypertrophy, 
increases myocardial oxygen demand (MVO2), and accelerates endothelial 
dysfunction and atherosclerosis. The rapid diastolic runoff can compromise 
coronary perfusion pressure, thereby predisposing the patient to development of 
subendocardial ischemia. 
SECONDARY HYPERTENSION 
Secondary hypertension accounts for approximately 5-10% of all cases of 
hypertension. It has an identifiable cause. This form of high blood pressure tends 
to appear suddenly and often causes higher blood pressure than primary 
hypertension. Patient with secondary hypertension are best treated by controlling 
or removing the underlying disease or pathology although they may still require 
antihypertensive drugs. 
Causes of secondary hypertension: 
1. Renal artery stenosis 
2. Chronic renal disease 
3. Primary hyperaldosteronism 
4. Stress and Sleep apnoea 
5. Hyper or Hypothyroidism 
6. Pheochromocytoma 
7. Aortic coarctation 
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8. Preeclampsia 
9. Drugs (oral contraceptives, NSAIDS, antidepressants, corticosteroids, 
sympathomimetics) 
There are many known conditions that can cause secondary hypertension. 
Regardless of the cause, arterial pressure becomes elevated either due to an 
increase in cardiac output, an increase in systemic vascular resistance or both. 
When cardiac output is elevated. it is generally due to either increased 
neurohumoral activation of the heart or increased blood volume. Increased 
systemic vascular resistance is most commonly caused, at least initially, by 
increased sympathetic activation or by the effects of circulating vasoconstrictors 
(eg angiotensin11). Anatomic considerations such as narrowing of the aorta (eg 
coarctation) or chronic changes in vascular structure (eg vascular hypertrophy) 
can also cause or contribute to increased systemic vascular resistance. 
MECHANISMS OF SECONDARY HYPERTENSION 
1. Renal artery stenosis (Reno vascular disease) 
Renal artery disease can cause narrowing of the vessel lumen (stenosis). 
The reduced lumen diameter decreases the pressure at the afferent arteriole and 
reduces renal perfusion. This stimulates renin release by the kidney, which 
increases circulating angiotensin II and aldosterone. These hormones increase 
blood volume by enhancing renal reabsorption of sodium and water. 
Increased angiotensin-II also causes systemic vasoconstriction and 
enhances sympathetic activity. Chronic elevation of angiotension II promotes 
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cardiac and vascular hypertrophy. The net effect of these renal mechanisms is an 
increase in blood volume that augments cardiac output by Frank-Starling 
mechanism. Therefore hypertension caused by renal artery stenosis results from 
both increase in systemic vascular resistance and an increase in cardiac output. 
2. Chronic renal disease 
Any number of pathologic processes (eg diabetic nephropathy, 
glomerulonephritis) can damage nephrons in the kidney. When this occurs, the 
kidney cannot excrete normal amounts of sodium which leads to sodium and 
water retension, increased blood volume and increased cardiac output. Renal 
disease may also result in increased release of renin leading to renin dependent 
form of hypertension. 
3. Primary hyperaldosteronism 
Increased secretion of aldosterone generally results from adrenal adenoma 
or adrenal hyperplasia. Increased circulating aldosterone causes renal retention of 
sodium and water which causes blood volume and arterial pressure to increase. 
Plasma renin levels are generally decreased as the body attempts to suppress the 
renin- angiotensin system. 
4. Stress 
Emotional stress leads to activation of sympathetic nervous system, which 
causes increased release of norepinephrine from sympathetic nerves in the heart 
and blood vessels leading to an increased cardiac output and an increased 
systemic vascular resistance.  Furthermore adrenal medulla secretes more 
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catecholamines. Activation of sympathetic nervous system increases circulating 
angiotensin II, aldosterone and vasopressin which can increase systemic vascular 
resistance. 
Prolonged activation of angiotensin11 and catecholamines can lead to 
cardiac and vascular hypertrophy both of which can contribute to a sustained 
increase in blood pressure. 
5. Sleep apnea 
It is a disorder in which people repeatedly stop breathing for short periods 
of time (10 - 30 sec) during their sleep. These individuals have a high incidence 
of hypertension and the mechanism of hypertension may be due to sympathetic 
activation and hormonal changes associated with repeated periods of apnea 
induced hypoxia and hypercapnea and from stress associated with loss of sleep. 
6. Hyperthyroidism and hypothyroidism 
 Both can lead to hypertension and the mechanisms of poorly 
understood. Elevated thyroxine levels cause increased blood volume through 
activation of renin-angiotensin-aldosterone system and increased heart rate and 
ventricular contractility. Recent studies suggest that cardiac changes are 
independent of sympathetic activity. Subnormal thyroxine levels reduce tissue 
metabolism, which may decrease the production of tissue vasodilator metabolites 
and endothelial production of nitric oxide and cause vasoconstriction and 
increased arterial pressure. There is also an increase in arterial stiffness. 
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7. Pheochromocytoma 
 Catecholomine secreting tumors of adrenal medulla can lead to very 
high levels of circulating catecholamines. This leads to alpha receptor mediated 
systemic vasoconstriction and beta receptor mediated cardiac stimulation both 
contribute to significant elevations in arterial pressure. The pheochromocytoma 
is diagnosed by measuring plasma or urine catecholomine levels and their 
metabolites (vanillylmandelic acid and metanephrine). 
8. Pre eclampsia 
 This condition sometimes develops during second and third trimesters 
of pregnancy that causes hypertension due to increased blood volume and 
tachycardia. 
9. Aortic coarctation 
 It is a congenital defect commonly found just distal to the left 
subclavian artery in the arch of aorta. This leads to reduced distal arterial 
pressure and elevated arterial pressure in the head and arms. The reduced arterial 
pressure activates renin-angiotensin-aldosterone system which leads to an 
increase in blood volume. This further increases pressure in upper body and may 
offset the reduction in lower body arterial pressure. This condition is diagnosed 
by greater arterial pressure in arms compared to arterial pressure in the legs. 
Because this is a chronic condition, baroreceptors are desensitized and upper 
body arterial pressure remains elevated because of increased cardiac output to 
these parts of  body. 
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CONSEQUENCES OF HYPERTENSION 
Hypertension is an independent predisposing factor for heart failure, 
coronary artery disease, stroke, renal disease, and peripheral arterial disease. 
1. HEART 
Heart disease is the most common cause of death in hypertensive patients. 
Hypertensive heart disease is the result of structural and functional adaptations  
leading  to  left  ventricular  hypertrophy, congestive heart failure, abnormalities  
of blood flow  due  to  atherosclerotic coronary  artery  disease and micro 
vascular disease, and cardiac arrhythmias. Both genetic and hemodynamic 
factors contribute to left ventricular hypertrophy. Clinically, left                    
ventricular hypertrophy can be diagnosed by electrocardiography, although  
echocardiography  provides  a  more  sensitive measure  of left  ventricular  wall  
thickness.  Individuals with left ventricular hypertrophy  are  at  increased  risk 
for  coronary heart disease,  stroke, congestive heart failure, and sudden  death. 
Congestive heart failure may be related to systolic dysfunction, diastolic 
dysfunction, or a combination of the two. Abnormalities of diastolic function that 
range from asymptomatic heart disease to overt heart failure are common in 
hypertensive patients. Approximately one-third of patients with congestive heart 
failure have normal systolic function but abnormal diastolic function 
Diastolic dysfunction is an early consequence of hypertension-related 
heart disease and is exacerbated by left ventricular hypertrophy and ischemia.  
Cardiac catheterization provides the most accurate assessment of diastolic 
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function and it can be evaluated by several noninvasive methods, including 
echocardiography and radionucleotide angiography. 
2. BRAIN 
 Stroke  is  the  second  most  frequent  cause  of  death  in the  world;  it  
accounts  for  5  million  deaths  each  year, with  an  additional  15  million  
persons  having  nonfatal strokes. Elevated blood pressure is the strongest risk 
factor for stroke. Approximately 85% of strokes are due to infarction, and the 
remainders are due to either intracerebral or subarachnoid hemorrhage. The 
incidence of stroke rises progressively with increasing blood pressure levels, 
particularly systolic blood pressure in individuals > 65 years. 
 Hypertension is also associated with impaired cognition in an aging 
population. Hypertension-related cognitive impairment and dementia may be a 
consequence of a single infarct due to occlusion of a “strategic”  larger vessel or 
multiple lacunar infarcts due to occlusive small vessel disease resulting in 
subcortical white matter ischemia. Cerebral blood flow remains unchanged over 
a wide range of arterial pressures (mean arterial pressure of 50–150 mmHg) 
through a process termed autoregulation of blood flow.  In patients  with the  
clinical  syndrome of  malignant  hypertension,  encephalopathy  is  related to  
failure  of  autoregulation  of  cerebral  blood  flow  at the  upper  pressure  limit,  
resulting in vasodilation and hyperperfusion. Untreated hypertensive  
encephalopathy  may  progress  to  stupor, coma,  seizures,  and  death  within  
hours. 
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3. KIDNEY 
The  kidney  is  both  a  target  and  a  cause  of  hypertension.  Primary 
renal disease is the most common etiology of secondary hypertension.  
Hypertension  is a  risk  factor  for  renal  injury  and  end-stage  renal  disease.  
Renal risk  appears  to  be  more  closely related  to  systolic  than  to  diastolic  
blood  pressure for developing end stage renal disease  at  every  level  of  blood  
pressure. Proteinuria is a reliable marker of the severity of chronic kidney 
disease and is a predictor of  its  progression. 
Patients with high urine protein excretion (>3 g/24 h) have a more rapid 
rate of progression than do those with lower protein excretion rates. 
Atherosclerotic, hypertension-related vascular lesions in the kidney primarily 
affect preglomerular arterioles, resulting in ischemic changes in the glomeruli 
and postglomerular structures.  Glomerular injury also may be a consequence of 
direct damage to the glomerular capillaries due to glomerular hyperperfusion. 
With progressive renal injury there is a loss of autoregulation of renal 
blood flow and glomerular filtration rate, resulting in a lower blood pressure 
threshold for renal damage and a steeper slope between blood pressure and renal 
damage. The result may be a vicious cycle of renal damage and nephron loss 
leading to more severe hypertension, glomerular hyperfiltration, and further renal 
damage. Glomerular pathology progresses to glomerulosclerosis, and eventually 
the renal tubules may also become ischemic and gradually atrophic. 
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The renal lesion associated with malignant hypertension consists of 
fibrinoid necrosis of the afferent arterioles, sometimes extending into the 
glomerulus, and may result in focal necrosis of the glomerular tuft. Clinically, 
macroalbuminuria (a random urine albumin/creatinine ratio >300 mg/g) or 
microalbuminuria (a random urine albumin/creatinine ratio 30–300 mg/g) are 
early markers of renal injury.  These are also risk factors for renal disease 
progression and cardiovascular disease. 
4. VASCULAR COMPLICATIONS 
In addition to contributing to the pathogenesis of hypertension, blood  
vessels  may  be  a  target  organ  for atherosclerotic  disease  secondary  to  
long-standing elevated  blood  pressure.  Hypertensive patients with arterial 
disease of the lower extremities are at increased risk for future cardiovascular 
disease. Although patients with stenotic lesions of the lower extremities may be 
asymptomatic, intermittent claudication  is  the  classic  symptom of  Peripheral 
arterial disease (PAD). This is characterized by aching pain in the calves or 
buttocks while walking that is relieved by rest. 
The ankle-brachial index is a useful approach for evaluating peripheral 
arterial disease and is defined as the ratio of noninvasively assessed ankle to 
brachial (arm) systolic blood pressure. An ankle-brachial index < 0.90 is 
considered diagnostic of peripheral arterial disease and is associated with > 50% 
stenosis in at least one major lower limb vessel. Several studies suggest that an 
ankle-brachial index < 0.80 is associated with elevated blood pressure, 
particularly systolic blood pressure. 
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Hypertensive patients have stiffer arteries, and arteriosclerotic patients 
may have particularly high systolic blood pressures and wide pulse pressures as a 
consequence of decreased vascular compliance due to structural changes in the 
vascular wall. Recent evidence suggests that arterial stiffness has independent 
predictive value for cardiovascular events. Clinically, a number of devices are 
available to evaluate arterial stiffness or compliance, including ultrasound and 
magnetic resonance imaging (MRI). 
Vascular endothelial function also modulates vascular tone. The vascular 
endothelium synthesizes and releases a spectrum of vasoactive substances, 
including nitricoxide, a potent vasodilator. Endothelium-dependent vasodilation 
is impaired in hypertensive patients.  This in turn leads to endothelial injury and 
atherosclerotic changes in the vessel wall. Endothelin is a vasoconstrictor peptide 
produced by the endothelium, and orally active endothelin antagonists may lower 
blood pressure in patients with resistant hypertension. 
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ATHEROSCLEROSIS 
DEFINITION 
Atherosclerosis is a thickening and hardening of large and medium-sized 
muscular arteries, primarily due to involvement of tunica intima and is 
characterised by fibrofatty plaques or atheromas. The term atherosclerosis is 
derived from athero-(meaning porridge) referring to the soft lipid-rich material in 
the centre of atheroma, and sclerosis (scarring) referring to connective tissue in 
the plaques. 
Atherosclerosis is the commonest and the most important of the arterial 
diseases. Though any large and medium-sized artery may be involved in 
atherosclerosis, the most commonly affected are the aorta, the coronaries and the 
cerebral arterial systems. 
Risk factors 
Following risk factors which are associated with increased risk of 
developing clinical atherosclerosis. They are acting in combination rather than 
singly. These risk factors are divided into two groups. 
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RISK FACTORS FOR ATHEROSCLEROSIS 
 
PATHOGENESIS 
Atherosclerosis is a multi factorial process whose exact pathogenesis is 
still not known. 
1.  Reaction-to-Injury Hypothesis 
This theory is most widely accepted and incorporates aspects of two older 
historical theories of atherosclerosis-the lipid theory of Virchow and 
thrombogenic theory of Rokitansky. 
Major Risk factors Emerging Risk factors 
A) Modifiable 1.Environmental influences 
2.Obesity 
3.Hormones: Oestrogen deficiency, Oral 
contraceptives 
4.Physical inactivity 
5.Stressful life 
6.Homocystinuria 
7.Alcohol 
8.Prothrombotic factors 
9.Infections(Herpes virus, Cytomegalo virus) 
10.High C- Reactive Protein 
1.Dyslipidaemia 
2.Hypertension 
3.Diabetes mellitus 
4.Smoking 
B) Constitutional 
1.Age 
2.Sex 
3.Genetic factors 
4.Familial and racial Factors 
  
PATHOGENESIS OF ATHEROSCLEROSIS 
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The original response to injury theory was first described in 1973 
according to which the initial event in atherogenesis was considered to be 
endothelial injury followed by smooth muscle cell proliferation so that the early 
lesions, according to this theory, consist of smooth muscle cells mainly. The 
modified response-to-injury hypothesis described subsequently in 1993 
implicates lipoprotein entry into the intima as the initial event followed by lipid 
accumulation in the macrophages (foam cells) which according to modified 
theory, are believed to be the dominant cells in early lesions. 
Role of key components involved in Atherogenesis 
i) Endothelial injury 
It has been known for many years that endothelial injury is the initial 
triggering event in the development of lesions of atherosclerosis. Endothelial 
dysfunction may initiate the sequence of events. Various causes of endothelial 
injury are: mechanical trauma, haemodynamic forces, immunological and 
chemical mechanisms, metabolic agent as chronic dyslipidaemia, homocysteine, 
circulating toxins from systemic infections, viruses, hypoxia, radiation, carbon 
monoxide and tobacco products. 
In humans, two of the major risk factors which act together to produce 
endothelial injury are: 
1. Haemodynamic stress from hypertension. The role of haemodynamic forces in 
causing endothelial injury is further supported by the distribution of 
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atheromatous plaques at points of bifurcation or branching of blood vessels 
which are under greatest shear stress. 
2. Chronic dyslipidaemia 
ii)  Intimal smooth muscle cell proliferation 
Endothelial injury causes adherence, aggregation and platelet release 
reaction at the site of exposed subendothelial connective tissue and infiltration by 
inflammatory cells. Proliferation of intimal smooth muscle cells and production 
of extracellular matrix are stimulated by various cytokines such as IL-1 and 
TNF-α released from invading monocyte-macrophages and by activated platelets 
at the site of endothelial injury. These cytokines lead to local synthesis of growth 
factors such as Platelet-derived growth factor (PDGF) and fibroblast growth 
factor (FGF).They stimulate proliferation and migration of smooth muscle cells 
from their usual location in the media into the intima. 
Transforming growth factor-β (TGF-β) and interferon (IFN)-γ derived 
from activated T lymphocytes within lesions regulate the synthesis of collagen 
by smooth muscle cells. Smooth muscle cell proliferation is also facilitated by 
nitric oxide and endothelin released from endothelial cells. 
iii) Role of blood monocytes 
Though blood monocytes do not possess receptors for normal Low 
density lipoprotein (LDL), low density lipoprotein does appear in the monocyte 
cytoplasm to form foam cell. Plasma low density lipoprotein on entry into the 
intima undergoes oxidation. The ‘oxidised Low density lipoprotein’ formed in 
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the intima performs the following all-important functions on monocytes and 
endothelium: 
a) For monocytes:  Oxidised  low density lipoprotein acts to attract, proliferate, 
immobilise and activate them as well as is readily taken up by scavenger receptor 
on the monocyte to transform it to a lipid laden foam cell. 
b) For endothelium:  Oxidised low density lipoprotein is cytotoxic. Death of 
foam cell by apoptosis releases lipid to form lipid core of plaque. 
iv) Role of dyslipidaemia 
Chronic dyslipidaemia in itself may initiate endothelial injury and 
dysfunction by causing increased permeability. In particular, 
hypercholesterolemia with increased serum concentration of low density 
liporotein promotes formation of foam cells, while high serum concentration of 
High density lipoprotein (HDL) has anti-atherogenic effect. 
Thrombosis 
As apparent from the foregoing, endothelial injury exposes subendothelial 
connective tissue resulting in formation of small platelet aggregates at the site 
and causing proliferation of smooth muscle cells. This causes mild inflammatory 
reaction which together with foam cells is incorporated into the atheromatous 
plaque. The lesions enlarge by attaching fibrin and cells from the blood so that 
thrombus becomes a part of atheromatous plaque. 
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The lesions of athrosclerosis begin with fatty streaks and gelatinous lesions. Full 
blown atheromatous lesions or fibrofatty plaques have a superficial cap and 
cellular or soft centre. Complicated atheromas may have dystrophic calcification, 
ulceration, thrombosis, haemorrhage and aneurysm formation. 
Major clinical effects of atherosclerosis are on the 
1. Heart -coronary artery disease 
2. Brain- stroke 
3. Aorta - aneurysmal dilatation 
4. Intestine- ischaemia 
5. Lower extremities- gangrene. 
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INTERARM BLOODPRESSURE DIFFERENCE 
 
The  inter-arm  difference  (IAD)  in  blood  pressure  has  received  
attention  globally was  discovered  by  Osler  in  1915  who  noted first. The 
inter-arm blood pressure difference  is an easily obtained and non-invasive 
parameter that clinical practitioners have investigated since the early 20th 
century. Hypertension guidelines recommend  that  blood  pressure  should  be 
assessed in  both arms at the initial visit, because differences exist and 
measurement in only  one  arm may  lead  to  underdiagnosis  of  hypertension. 
These  guidelines also suggest that  arm  with the  higher  values  should  be  
used  for subsequent  measurements. 
When both arms are measured, it has been suggested  that  simultaneous  
measurement  of both  arms  seems  preferable  since  sequential measurement  
of  BP  overestimates  the prevalence of systolic inter arm blood pressure 
difference.  An  average  of  at  least  three  observations  of blood  pressure  
should  be  used  to  identify  the interarm  blood  pressure  difference  in the  left 
and  right  arm  of  patients  diagnosed  with severe diseases. 
Arm blood pressure is generally higher on the right side than on the left, 
because the left subclavian artery originates from the aorta, thus making an acute 
angle, in contrast to the right artery. This acute angle leads to turbulent flow that 
reduces blood flow and blood pressure, therefore leading to an inter arm blood 
pressure difference. 
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Right and left arm pressure differences of  a few mm of Hg are quite 
normal, but more than 10 mm of  Hg  could  significantly  increase  the  risk  for 
cardiovascular  outcomes,  including  increased cardiovascular mortality and all-
cause mortality. In  a  recent meta-analysis  of  20  studies,  a  systolic  blood  
pressure difference  of  more  than  15  mm  Hg  between  the  right  and left  arm  
was  associated  with  a  2.5  greater  risk  of peripheral  vascular  disease,  a  1.7  
fold  increase  in cardiovascular  mortality,  and  a  1.6  higher  risk  of  all cause  
death .  It  has  been  suggested that  inter-arm  blood  pressure  difference  may  
also  be associated with an increased propensity for strokes. 
CAUSES FOR INTERARM PRESSURE DIFFERENCE 
Differences  in  blood  pressure  between  arms  may  have  a number  of  
causes  such  as 
1.  Subclavian artery stenosis (due to atherosclerosis) 
2. Aortic aneurysm and aortic coarctation 
3. Vasculitis 
4. Fibro muscular hyperplasia 
5. Connective tissue disorders 
6. Thoracic outlet compression. 
Most  common diagnostic  entity  would  be  subclinical  atherosclerosis  
as suggested  by  the  increased  likelihood  of  finding  an interarm difference in 
blood pressure  and peripheral arterial disease. 
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Prevalence of Interarm systolic bloodpressure difference (IASBPD) 
The reported prevalences of interarm blood pressure differences  vary 
greatly;  they are usually higher in the presence of hypertension. Meta analysis of 
recent studies on  prevalences  of  a  systolic  interarm blood pressure difference 
≥10 mmHg  were  11.2%  for  seven  populations  with  hypertension, 7.4%  for  
six  populations  with  diabetes and 3.6%  for  eight  community based  groups  
without  diabetes  or  hypertension.The  corresponding  prevalences  for  
interarm pressure differences  ≥15 mmHg  were  4.0%   in  hypertension  2.3%    
in  diabetes  and  0.7% without  diabetes  or  hypertension (five  cohorts). Gaynor 
et al in his study observed that 40.3% patients with stroke had an IASBPD 
>10mmHg. 
IASBPD and Coronary artery disease 
Kim et al. Medicine (2016) in his study observed, Coronary artery disease 
and cerebrovascular disease were more common in patients with significant 
systolic inter arm blood pressure difference. There was no significant difference 
in the prevalence of cardiovascular disease and cerebrovascular disease between 
patients with and without significant diastolic interarm pressure difference. The 
10-year cardiovascular risk  calculated by using the Framingham risk score was 
9.3±7.7% in all patients, and male patients showed a higher risk of 12.9±7.5% 
(female patients: 5.2±5.5%). Results from multiple regression analysis show that 
the 10-year cardiovascular risk was weakly but significantly correlated with 
systolic interarm blood pressure difference. 
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S.-J. Park et al. in his study showed that interarm blood pressure 
difference, especially corrected- interarm blood pressure difference (BP-adjusted 
IABPD) is associated with the severity of coronary artery disease as indicated by 
the Gensini score. Thus, corrected- interarm blood pressure difference is an 
easily measured parameter that may be useful in clinical practice. A novel 
finding of their study is that corrected- interarm blood pressure difference had a 
linear correlation with the severity of coronary atherosclerosis (based on the 
Gensini score). Takanori Tokitsu et al in his study concluded that systolic 
interarm blood pressure differences were increased in coronary artery disease 
patients and correlated with its severity. Greater than 10 mmHg of inter arm 
difference of blood pressure was independently associated with future 
cardiovascular events. Assessing Interarm difference in blood pressure by Ankle 
Brachial Index measurement may facilitate risk stratification in coronary artery 
disease patients. 
IASBPD and stroke 
Clark et al 2012 in his systematic review and meta-analysis found, five 
cohorts (four non-invasive studies) reported a significant association between 
cerebrovascular disease and interarm blood pressure differences of 15 mm Hg or 
more. Pooled sensitivity was 8% and specificity 93%. Hirofumi Tomiyama et al 
in his article revealed that even mild inter arm difference in blood pressure, 
assessed by simultaneous measurement (≥ 5 mm Hg) is a predictor of Ankle 
Brachial Index < 0.90 in Japanese subjects with/without a past history of 
cardiovascular disease, and that inter arm blood pressure difference of  ≥ 15 mm 
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Hg is a predictor of the  future development of stroke in Japanese subjects 
without a past history of cardiovascular disease. These findings of the present 
study might emphasize the significance of the recommendation to measure blood 
pressure  in both arms at the first visit. 
Jinkwon Kim et al in his study concluded that the presence of interarm 
systolic or diastolic blood pressure difference >10 mm Hg is a strong 
independent prognostic marker in acute ischemic stroke. 
IASBPD and peripheral arterial disease 
 Clark et al 2012 in his systematic review and meta-analysis observed, 
nine non-invasive studies showed that systolic interarm blood pressure difference 
of 15 mm Hg or more was linked with peripheral vascular disease in the leg, 
defined by direct measurement of ankle-brachial pressure index of less than 0·9 
(five studies). In the Multi-Ethnic Study of Atherosclerosis, the presence of an 
inter arm systolic pressure difference of 15 mm Hg was associated with an 
increased risk of peripheral artery disease, an increased coronary calcium score 
and an increase in carotid intima-media thickness. 
 Jesper Mehlsen et al in their study observed that the mean numerical 
interarm difference in systolic blood pressure was higher in patients with definite 
peripheral artery disease compared to non- peripheral artery disease patients. In 
patients with definite peripheral artery disease, the numerical systolic blood 
pressure difference between arms exceeded 10 mmHg in 32.1%, 15 mmHg in 
49 
 
18.1%, 20 mmHg in 11.1%, and 25 mmHg in 6.7%. These values were 
significantly higher than in non- peripheral artery disease patients. 
IASBPD and subclavian stenosis 
From five case series of patients with angiographically proven 
asymptomatic subclavian stenosis (defined as >50% occlusion), for two studies 
the estimated mean blood pressure was 36·9 mm Hg lower in the arm with 
stenosis than in the other. The difference was similar in two other studies that 
could not be pooled (41 mm Hg and 21 mm Hg); one further study showed a 
mean intra-arterial pressure gradient of 28 mm Hg  across stenoses of more than 
75% in ten patients. Inter arm systolic blood pressure difference >10 mm/Hg has 
been shown to have a high sensitivity and a low specificity for angiographically 
significant subclavian artery stenosis. 
IASBPD and Left ventricular hypertrophy 
Lee W-H, et al. in his study observed that  patients with an interarm 
systolic blood pressure difference ≥10 mmHg had higher prevalence of 
hypertension, higher mean arterial pressure, higher BMI, higher prevalence of 
ankle-brachial index 0.9, higher brachial ankle pulse wave velocity, higher Left 
Ventricular Mass Index and higher prevalence of concentric left ventricular 
hypertrophy. 
Atherosclerosis directly caused a decrease in blood perfusion in the lower 
extremities and an increase in arterial wall stiffness, contributing to decreasing 
ankle-brachial index and arterial distensibility, and then final progressed to left 
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ventricular hypertrophy. Reversely, left ventricular hypertrophy caused a 
decrease in cardiac output, which further deteriorated deficiency of blood 
perfusion of the extremities and promoted the progression of peripheral arterial 
disease and increased interarm systolic blood pressure difference. 
Arterial stiffness is associated with hypertrophy and atherosclerosis within 
the capacitance arteries that result in an increase in pulse wave velocity and 
consequent alterations in the pressure waveform and increases in systolic and 
pulse pressure. Alterations in wave reflections combined with increased stiffness 
may also contribute to left ventricular hypertrophy. Atherosclerosis and left 
ventricular hypertrophy may be possible mechanisms responsible for the 
association between an interarm systolic blood pressure difference of 10 mmHg 
or more and adverse cardiovascular outcomes. 
Dellegrottaglie et al. evaluated the association between carotid-femoral 
pulse wave velocity and Left Ventricular Mass Index in chronic kidney disease 
and found a positive correlation between carotid-femoral pulse wave velocity 
and Left Ventricular Mass Index. Above mention studies revealed that detection 
of an interarm systolic blood pressure difference may provide a simple method of 
detecting patients at increased risk of atherosclerosis and cardiovascular 
complications. 
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CAROTID INTIMA MEDIA THICKNESS 
.        Carotid ultrasound has become a prominent focus of research and carotid 
intima–media thickness (CIMT) in particular has received attention as a safe, 
noninvasive and cost effective method to detect early atherosclerotic vascular 
diseases and cardiovascular disease  risk. 
In 1986, Pignoli et al. demonstrated that B-mode ultrasound was a useful 
method for the measurement of carotid intima–media thickness, where it appears 
as a ‘double echo’ in the artery wall.  In 1991, Salonen and colleagues showed 
for the first time the in vivo use of ultrasound imaging for the evaluation of 
atherosclerotic changes in the carotid arteries. Since then, further studies have 
shown that the measurement of carotid intima–media thickness by B-mode 
ultrasound is reliable and reproducible. 
In 2010, the American College of Cardiology Foundation (ACCF)/ 
American Heart Association (AHA) published their own guidelines for the 
assessment of cardiovascular risk in asymptomatic individuals. In the guideline, 
it is recommended that carotid intima–media thickness could be measured for the 
purposes of aiding cardiovascular risk classification in asymptomatic adults who 
are deemed to be at an intermediate risk. 
Carotid intima–media thickness is defined as the distance between the 
lumen–intima interface and the media–adventitia interface. The process 
underlying intimal thickening is not fully understood but is thought to be due to 
underlying atherosclerosis.  Atherosclerosis is a generalized process that affects 
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all arterial beds, including the carotid and coronary arteries. Thus atherosclerosis 
in the carotids should reflect coronary involvement, a fact that has been 
confirmed histologically by autopsy studies and concurrent atherosclerotic 
change visualized in the coronary arteries during angiography. Extracranial 
carotid arteries provide excellent and reproducible sites for intima- media 
thickness assessment because of accessibility, adequate size, and limited 
movement 
Relations with established risk factors 
There is a wealth of evidence on the relation between risk factors and 
increased carotid intima–media thickness which strengthen the notion that the 
measurement reflects atherosclerosis and increased cardiovascular risk. 
Traditional risk factors such as ageing, male gender, hypertension, increased 
body mass index, high low density lipoprotein (LDL) cholesterol, low high-
density lipoprotein (HDL) cholesterol, diabetes and smoking have shown to be 
related to increased carotid intima–media thickness. 
Of all traditional risk factors, hypertension appears to contribute most, 
probably through medial hypertrophy. The direction of the associations is 
generally similar in male and female. Subjects with a history of cardiovascular 
disease tend to have higher carotid intima–media thickness measurements as 
compared to those without a history of cardiovascular disease. Cumulative 
effects of cardiovascular risk factors on carotid intima–media thickness have 
been shown by the positive relationship with the Framingham risk score. 
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In addition to established risk factors, a number of new or emerging risk 
factors have been related with carotid intima–media thickness. For example, 
inflammation, as measured by C-Reactive Protein (CRP) is of critical importance 
in the pathogenesis of atherosclerosis. Elevated levels of C-reactive protein have 
been associated with increased carotid intima–media thickness. Finally, 
increased carotid intima–media thickness has been associated with 
atherosclerotic abnormalities in other organ systems, including the brain, heart, 
kidneys, lower limb arteries and brachial artery. 
CIMT as a predictor of coronary artery disease and stroke 
Early data from multiple large epidemiological studies showed that 
intima-media thickness is correlated with the extent of atherosclerosis in the 
coronary arteries.  In the Kuopio Ischaemic Heart Disease Risk Factor Study, 
Intimal thickening of the carotid artery wall was found to be predictive of 
incident myocardial infarction (MI), with a 0.1-mm increase in intima-media 
thickening in representing an 11% increase in risk of myocardial infarction. In 
the Atherosclerosis Risk in Communities (ARIC) study, extreme mean carotid 
intima media thickness > 1 mm was associated with an increased incidence of 
cardiovascular disease for both women and men. 
The Cardiovascular Health Study examined carotid intima media 
thickness in relation to future risk of myocardial infarction and stroke, subjects in 
the higher quintiles of maximal intima media thickness had an increased relative 
risk for myocardial infarction or stroke compared with those in the lower 
quintiles. In the Rotterdam Study, intima media thickness measured in the 
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common carotid artery, at the bifurcation and the combined measure were all 
significantly associated with incident myocardial infarction and stroke. In the 
Carotid Atherosclerosis Progression Study, intima media thickness measured in 
the common carotid artery and bifurcation remained predictive for myocardial 
infarction and stroke.  In the Malmo Diet and Cancer Study, common carotid 
intima media thickness was associated with the incidence of stroke, independent 
of the presence of carotid plaque. 
EUROPEAN SOCIETY OF CARDIOLOGY GUIDELINES (ESC) FOR 
MEASUREMENT OF CIMT 
Examination of the carotid wall gives an opportunity to evaluate 
subclinical alterations in wall structure that precede and predict future 
cardiovascular clinical events. B-mode ultrasonography is a noninvasive, safe, 
easily performed, reproducible, sensitive, relatively inexpensive and widely 
available method for detection of early stages of atherosclerosis and is accepted 
as one of the best methods for evaluation of arterial wall structure. 
Intima media thickness is defined as a double-line pattern visualised by 
echo 2D on both walls of the common carotid artery (CCA) in a longitudinal 
view. Two parallel lines (leading edges of two anatomical boundaries) form it: 
lumen-intima and media-adventitia interfaces. 
CURRENT RECOMMENDATIONS FOR IMT MEASUREMENT 
TYPE OF EQUIPMENT 
 High-resolution B-mode system equipped with a linear array 
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transducer >7 MHz with minimal compression (<10:1) and 
footprint of at least 3 cm 
OBSERVATIONS RECOMMENDED 
1. Inclusion of carotid bifurcation in the image plane serving as a   landmark 
to provide accurate serial measurements 
2. Intima media thickness measurement along a segment of the artery free of 
atherosclerotic plaque with clearly defined lumen-intima and media-
adventitia interfaces 
3. 10-mm-in-length straight arterial segment is required 
4. Intima media thickness measured in triplicate 
5. The far wall of the common carotid artery is preferred 
6. Arterial wall segments assessed longitudinally and perpendicular to the 
ultrasound beam 
7. Lateral probe position is preferred 
8. Horizontal position of the artery in the image sector to optimise the 
visualization of lumen-intima interface 
9. Intima media thickness measurement at a distance of at least 5 mm below 
the distal end of Common carotid artery (CCA) (Intima media thickness 
could also be measured at the carotid bifurcation and internal carotid artery 
bulb, but the values should be given separate) 
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MEASUREMENT GUIDELINES 
1. Automatic or semi-automatic intima media thickness measurement, online 
or offline 
2. Common carotid artery diameter (inter-adventitial and intraluminal) 
should also be measured (it correlates significantly with Intima media 
thickness) 
3. Intima media thickness measured at end-diastole (R wave) 
DATA TREATMENT 
1. Intima media thickness  values averaged 
2. Mean Intima media thickness values are preferred (more reproducible 
than maximal values).Increased reproducibility of intima media thickness 
measurement when values from right and left common carotid artery are 
combined. 
NORMAL VERSUS ABNORMAL VALUES 
Normal intima media thickness values and reference ranges are age and 
sex dependent there is a significant steady increase in intima media thickness 
with advancing age in all carotid segment and significantly higher intima media 
thickness values in men than in women. 
Normal value of carotid intima media thickness is difficult to obtain 
because the absolute values depends also on location of measurement (segment 
of artery, near or far wall), body habitus, ultrasound equipment used, imaging 
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depth, off line recording system (automated or manual tracking) and imaging 
quality obtained. 
The American Society of Echography (ASE) Task force recommends that  
intima media thickness ≥75th percentile is considered high and indicative of 
increased cardiovascular risk. Values from the 25th to the 75th percentile are 
considered average and indicative of unchanged cardiovascular risk. Values            
≤ 25th percentile are considered low and indicate lower than the expected 
cardiovascular risk. 
In the latest European Society of Cardiology hypertension guidelines 
(2013) carotid intima media thickness > 0.9 mm has been re-confirmed as a 
marker of asymptomatic organ damage, although it has been proven that in 
middle-aged and elderly patients the threshold values indicating high 
cardiovascular risk are higher. 
V. Mohan et al.: (Intimal medial thickness in S. Indians) in his study 
evaluate normal intima-medial thickness of common carotid artery by B-mode 
ultrasound imaging and it was 0.74 ± 0.14 mm. Some studies also indicated that 
Carotid intima media thickness < 0.8 mm is associated with normal healthy 
individuals, and a value at or above 1 mm is associated with cardiovascular 
disease risk in any age group 
Intima-media thickness is accepted as a marker of subclinical 
atherosclerosis and Intima-media thickness screening can help to reclassify a 
substantial proportion of intermediate cardiovascular risk patients into a lower or 
higher risk category. 
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MATERIALS AND METHODS 
PLACE OF STUDY 
Study was conducted in the Department of Medicine and Department of 
Radiology, Government Rajaji Hospital in co-ordination with the Institute of 
Physiology, Madurai Medical College, Madurai for a period of eight months. 
ETHICAL COMMITTEE 
Approval obtained from the ethical committee of Government Rajaji 
Hospital, Madurai. 
STUDY DESIGN 
Cross sectional study 
SAMPLE SIZE 
Total subjects   - 100 
STUDY POPULATION 
Both male and female hypertensive patients with coronary artery disease 
and stroke admitted in Medicine ward, GRH, Madurai. 
INCLUSION CRITERIA: 
1. Hypertensive patients with coronary artery disease and stroke. 
2. Age: 45- 70 years. 
3. Both male and female. 
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EXCLUSION CRITERIA: 
1. Vasculitis 
2. Connective tissue disorders 
3. Aortic coarctation 
4. Thoracic outlet syndrome 
5. Atrial fibrillation 
6. Traumatic and radiation injury to carotid artery. 
7. Diabetes mellitus   and chronic kidney disease. 
8. Previous history of  coronary artery disease/ stroke 
MATERIALS USED FOR STUDY 
1. Proforma – to record the anthropometric measurements and the clinical 
findings of   the subjects. 
2. Portable weighing machine – to record the body weight in kilograms. 
3. Inch tape – to   measure the standing   height in centimeters. 
4. Automated blood pressure measuring device (Omron HEM8712) -For 
recording interarm systolic blood pressure difference between both the 
arms. 
5. Doppler USG Philips ultrasound machine – For measuring carotid     
intima media thickness. 
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METHODOLOGY: 
The study was initiated after obtaining permission from Department of 
Medicine and Department of Radiology, Government  Rajaji  Hospital, Madurai. 
Hypertensive patients diagnosed as coronary artery disease and stroke 
and admitted in the inpatient Department of Medicine were selected for the 
study. In the above cases diagnosis was confirmed by ECG, ECHO and CT 
Brain. 
After getting informed written consent, detailed history was taken. 
General and Systemic examination was done. Blood samples were collected for 
baseline investigations. 
The experimental protocol includes 
1) RECORDING OF A DETAILED HISTORY 
History of present illness 
 Chest pain- Nature, any radiation, aggravated by exertion 
 Difficulty in breathing 
 Palpitations 
 Giddiness 
 Loss of consciousness 
 Weakness of upper limb or lower limb 
 Speech disturbance 
 Drooling of saliva 
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 Deviation of angle of mouth 
 Dysarthria 
 Dysphagia 
 Visual disturbance 
History of past illness 
 H/o similar episodes before 
 H/o Transient ischemic attack 
 H/o Hypertension 
 H/o Diabetes mellitus and Chronic Kidney Disease 
 H/o Peripheral vascular disease 
2) MEASUREMENT OF ANTHROPOMETRIC INDICES: 
The following were measured: 
Weight (in kilograms) was recorded using a portable standard weighing 
machine. 
Height (in centimeters) was measured to the nearest 0.5 cm using an inch tape. 
Body Mass Index (BMI) was calculated using Quetelet’s Index. 
BMI =   Weight (Kg)/ Height (m2). 
3) RECORDING OF VITAL SIGNS viz. pulse rate, respiratory rate, 
temperature were recorded and measurement of blood pressure was done as 
given below. 
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4) GENERAL EXAMINATION was done to elicit Pallor, Cyanosis, Icterus, 
Clubbing, Pedal edema, Lymphadenopathy. 
5) EXAMINATION OF CARDIOVASCULAR SYSTEM was done. 
6) EXAMINATION OF CENTRAL NERVOUS SYSTEM was done 
7) RECORDING OF INTERARM SYSTOLIC PRESSURE DIFFERENCE 
BP measurements of both the arms were done using an automated blood 
pressure measuring device (Omron HEM-8712).Standard BP measurement 
techniques were followed and cuff size was tailored to the arm of an individual 
according to their mid-arm circumference. 
BP was recorded simultaneously in both the arms following 5 minutes of 
rest with the patient in sitting position and with back support. The apparatus was 
kept at the level of heart during BP measurement. Recording of BP was repeated 
at 2 minutes interval for three times. The average of systolic BP for right arm 
was calculated and  then the average of systolic BP for left arm was calculated. 
The average systolic BP of right arm was considered as systolic BP of right arm 
and average systolic BP of left arm was considered as systolic BP of left arm. 
The difference between right arm systolic BP and left arm systolic BP was 
calculated. 
The interarm systolic BP difference was defined as the absolute difference 
of average systolic BP between the right arm and left arm. Absolute interarm 
systolic BP difference (IASBPD) was calculated by using the following formula. 
  
CAROTID INTIMA MEDIA THICKNESS 
MEASUREMENT BY CAROTID DOPPLER 
ULTRASOUND 
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ABSOLUTE INTERARM SYSTOLIC BLOOD PRESSURE 
DIFFERENCE = 
│Average Right arm systolic BP ─ Average Left arm systolic BP│ 
A large inter-arm systolic BP difference was defined as an absolute 
interarm systolic BP difference of greater than or equal to 10 mmHg. 
8) MEASUREMENT OF CAROTID INTIMA MEDIA THICKNESS 
In the Department of Radiology, Madurai Medical College. Doppler USG 
Philips ultrasound machine with 7- 14MHz frequency linear probe was used for 
measuring the carotid intima media thickness. 
The examination was carried out by the sonologist with each subject lying 
supine, neck slightly extended and turned contra laterally to the carotid artery 
being examined; continuous scans were done in the longitudinal and transverse 
planes after the application of ultrasound gel. All measurements of the intima-
media thickness was made in the longitudinal plane at the point of maximum 
thickness of the far wall of the common carotid artery (CCA) along a 1 cm 
section of the artery proximal to the carotid bulb. The position of the carotid bulb 
was defined as the point where the far wall deviated from the parallel plane of 
the distal common carotid artery. 
The carotid intima media thickness was defined as the distance between 
the inner echogenic line representing the intima-blood interface and the outer 
echogenic line representing the adventitia-media junction. After freezing the 
image, the measurement was made with electronic calipers. Measurements were 
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repeated for 3 times, unfreezing the image of each occasion and relocating the 
position of maximal intima-media thickness. The maximal thickness of the 
intima-media width at both right and left distal common carotid artery was 
measured to give a total of six readings. The mean value of each set of readings 
represented the mean intima-media thickness of each side. Mean carotid intima 
media thickness value of right side was considered as right side carotid intima 
media thickness value and mean left side carotid intima media thickness value 
was considered as left side carotid intima media thickness value. Mean value of 
right and left side carotid intima media thickness was calculated. 
Normal intima-medial thickness of common carotid artery by B-mode 
ultrasound imaging in Indians was 0.74 ± 0.14 mm and carotid intima media 
thickness < 0.8 mm was associated with normal healthy individuals. Carotid 
intima media thickness value at or above 0.8mm was considered abnormal. 
Carotid intima media thickness values at or above 1 mm was associated with 
cardiovascular disease risk in any age group. 
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RESULTS AND OBSERVATION 
 
The correlation between Interarm systolic blood pressure difference 
(IASBPD) and carotid intima media thickness (CIMT) was analysed by using 
Pearson’s correlation coefficient test. 
 
Interarm systolic blood pressure difference and Carotid intima media    
thickness were also correlated with other variables such as age,BMI and total 
cholesterol. All these correlations were done using the same Pearson’s 
correlation coefficient test. Gender association with IASBPD and CIMT was 
analysed by chi-square test. By means of SPSS (Statistical Package for Social 
Sciences) software version 21, analysis of statistics was performed. The 
statistical significance was drawn at ‘p’ value < 0.05. 
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1.INTERARM SYSTOLIC BLOODPRESSURE DIFFERENCE 
 
 
 
 
 
 
 
Table – 1 showing IASBPD of study population. Mean IASBPD was 7.2 ±  4.62 
mm/Hg. IASBPD ≥ 10mm/Hg was present in 31 cases. 
2. CAROTID INTIMA MEDIA THICKNESS 
 
 
 
 
 
 
 
 
 
Table – 2 showing CIMT of study population. Mean CIMT was 0.85±0.2 mm.  
CIMT ≥ 0.8mm was present in 49 cases. 
 
 
IASBPD (mm/Hg) No of cases 
< 10 69 
≥ 10 31 
Total 100 
MEAN± SD 7.2 ± 4.62 
CIMT in mm No of cases 
< 0.8 51 
≥ 0.8 49 
Total 100 
MEAN ± SD 0.85 ± 0.21 
  
 
3.  CORRELATION BETWEEN IASBPD AND CIMT 
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3. CORRELATION BETWEEN IASBPD AND CIMT 
 
 
 
 
 
 
 
 
 
 
Table – 3 showing correlation between IASBPD and CIMT of study 
population. Analysis was done using Pearson’s correlation coefficient test. There 
was  a statistically significant positive correlation between IASBPD and CIMT. 
 
 
 
 
 
 
 
 
 
Variable 
 
 
IASBPD in mm/Hg 
 
r value 
 
p value 
 
CIMT in mm 
 
 
0.885 
 
 
 
0.00001 
Significant 
 
 4. AGE DISTRIBUTION 
 
 
 
 
 
 
 
 
 
 
 
5. SEX DISTRIBUTION 
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4. AGE DISTRIBUTION 
Age  (years) No of cases 
45- 55 51 
56- 65 41 
66- 70 8 
Total 100 
MEAN± SD 56.16 ± 6.00 
 
 
Table - 4 showing age distribution of study population. Mean age was                
56.16 ± 6.00 years. 
 
5. SEX DISTRIBUTION 
 
 
 
 
 
 
 
 
Table – 5 showing sex distribution of study population. 
  
SEX No of cases 
Male 64 
Female 36 
Total 100 
 6. BODY MASS INDEX DISTRIBUTION 
 
 
7. TOTAL CHOLESTEROL 
 
 
0
10
20
30
40
50
60
70
80
< 200 ≥ 200 
N
O
 O
F
 C
A
S
E
S
TOTAL CHOLESTEROL  (mg/dl)
0
10
20
30
40
50
60
≤ 20 20.1- 24.9 25- 29.9 ≥ 30
N
O
 O
F
 C
A
S
E
S
BMI in kg/m2
69 
 
6. BODY MASS INDEX 
 
BMI(kg/m2) No of cases 
≤ 20 3 
20.1- 24.9 53 
25- 29.9 40 
≥ 30 4 
Total 100 
MEAN± SD 24.61 ± 2.43 
 
Table – 6 showing BMI of study population. Mean BMI was 24.61 ± 2.43 
kg/m2. 
 
7. TOTAL CHOLESTEROL 
 
 
 
 
 
Table – 7 showing total cholesterol of study population. Mean cholesterol                         
was 186 ± 15.748 mg/dl. Total cholesterol ≥ 200 mg/dl was present in 23 cases. 
 
Total cholesterol (mg/dl) No of cases 
< 200 77 
≥ 200 23 
Total 100 
MEAN± SD 186 ± 15.748 
  
 
8. CORRELATION BETWEEN IASBPD AND BMI 
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8. CORRELATION OF IASBPD WITH AGE, BMI AND CHOLESTEROL 
 
 
 
Table – 8 showing correlation of IASBPD with age, BMI and cholesterol 
of study population. Analysis was done using Pearson’s correlation coefficient 
test. There was a statistically significant positive correlation of IASBPD with 
age, BMI and total cholesterol. 
 
 
 
 
 
 
 
Variable 
IASBPD in mm/Hg 
r value p value 
AGE (years) 0.464 
0.00001 
significant 
BMI(kg/m2) 0.450 
0.00001 
significant 
TOTAL CHOLESTEROL 
(mg/dl) 
0.606 
0.00001 
significant 
  
 
9.CORRELATION BETWEEN CIMT AND BMI 
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9. CORRELATION OF CIMT WITH AGE, BMI AND CHOLESTEROL 
 
Table – 9 showing correlation of CIMT with age, BMI and total 
cholesterol of  study  population. Analysis was done using Pearson’s correlation 
coefficient test. There  was a statistically significant positive correlation of  
CIMT    with age, BMI and total cholesterol. 
 
 
 
 
 
 
 
 
Variable 
 
 
CIMT in mm 
 
 
r value 
 
 
p value 
 
 
 
AGE (years) 
 
0.555 
0.00001 
 
significant 
 
BMI(kg/m2) 
 
 
0.433 
0.00001 
 
significant 
 
TOTAL CHOLESTEROL 
(mg/dl) 
 
0.621 
 
0.00001 
 
significant 
 10.   ASSOCIATION BETWEEN IASBPD AND SEX 
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10. ASSOCIATION BETWEEN SEX AND IASBPD AND CIMT 
 
 
Table – 10 showing association of CIMT and IASBPD with sex. Analysis   
was done using chi-square test. There was no  significant association of sex with 
CIMT and IASBPD. 
 
 
 
 
 
 
 
 
 
Variable 
 
 
 
IASBPD < 10 
(mm/Hg) 
 
 
IASBPD≥10 
(mm/Hg) 
 
 
 
CIMT< 0.8 
(mm) 
 
 
CIMT≥ 0.8 
(mm) 
 
 
Male 
 
 
 
42 
 
 
22 
 
 
32 
 
 
32 
 
 
Female 
 
 
 
27 
 
 
9 
 
 
19 
 
 
17 
 
P Value 
 
 
0.33 
Insignificant 
 
0.78                                 
insignificant 
 
 
 
 
 
 
 
 
 
DISCUSSION 
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DISCUSSION 
Cardiovascular diseases account for approximately one third of all the 
deaths globally. Ischemic heart disease and stroke are the leading causes for 
cardiovascular disease burden. Among the risk factors for cardiovascular disease, 
hypertension increases cardiovascular disease risk by 2-3 fold. 
So early diagnosis of hypertension and identification of hypertensive   
patients at risk of future cardiovascular disease risk will reduce the mortality and 
morbidity due to cardiovascular diseases. By recording blood pressure difference 
between arms a simple method, patients at high risk of cardiovascular disease 
can be identified earlier and further progression of disease can be prevented by 
appropriate therapeutic measures. 
Various studies demonstrated that Interarm systolic BP difference ≥ 10   
mm/Hg was a predictor of future cardiovascular events. Kim et al. 2016 reported 
significant interarm systolic BP difference (IASBPD) was related to 10 years 
cardiovascular risk assessed by Framingham risk score. Significant correlation 
between interarm systolic BP difference and carotid intima media thickness 
(CIMT) was reported in a study conducted by Ma et al 2016. 
In view of the above perspective, the present study was conducted to 
study the correlation between interarm systolic blood pressure difference and 
carotid intima media thickness in hypertensive patients with coronary artery 
disease and stroke. In this study, correlation of Interarm systolic blood pressure 
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difference and carotid intima media thickness with other variables such as age, 
BMI, and total cholesterol was also evaluated. 
A total of 100 hypertensive patients with coronary artery disease (CAD) 
and stroke were selected for the study. Out of 100, 31 patients had coronary 
artery disease, 46 had stroke and 26 had both coronary artery disease and stroke. 
1. CORRELATION  BETWEEN  IASBPD AND CIMT 
Mean IASBPD in the study population was 7.2 mm/Hg. Out of 100 cases,  
IASBPD < 10 was present in 69 cases and IASBPD ≥ 10 was present in 31 cases. 
Mean CIMT in the study population was 0.85mm. Out of 100 cases, CIMT           
< 0.8mm  was present in 51 cases CIMT ≥ 0.8mm  was present in 49 cases. 
Upper extremity blood pressure differences are usually due to 
atherosclerosis involving the proximal vasculature supplying the upper 
extremity, resulting in a reduction in blood pressure in one upper extremity. In 
patients with subclavian or innominate atherosclerosis, 50% have concomitant 
coronary artery disease, 27% lower extremity artery involvement and 29% 
carotid obstructive disease. Patients with carotid artery disease often have 
multilevel atherosclerotic pathology including the origins of the sub-clavian 
arteries. 
Thereby systolic blood pressure difference in upper extremity is often 
related to anatomical correlation between atheromatous disease in the carotid,   
subclavian or the innominate artery. 
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Arterial stiffness is associated with hypertrophy and atherosclerosis within 
the capacitance arteries that results in an increase in pulse wave velocity and 
consequent alterations in the pressure waveform. Alterations in wave reflections 
combined with increased stiffness may contribute to augmentation of systolic 
BP. This in turn results in more pronounced interarm systolic BP difference. 
There was a statistically significant positive correlation between IASBPD 
and CIMT (P < 0.05) in this study. V.Aboyans et al, 2010., demonstrated an 
independent positive association between interarm systolic BP difference and 
carotid IMT in the United States cohort assessment(Multi- Ethnic Study of 
Atherosclerosis, MESA). They suggested that an interarm systolic BP difference 
≥ 15 mm Hg was associated with elevated carotid IMT values. 
MA et Al, 2016 documented that mean values of  carotid IMT were 
increased to a greater level  in the high IASBPD group. He concluded in his 
study that increased IASBPD was related to subclinical atherosclerosis and 
explained IASBPD can predict cardiovascular disease. The present study results 
were in accordance with above study results. 
H.-J. Hwang et al.2017, demonstrated that increased interarm systolic BP 
difference was associated with existent carotid plaque, but not to carotid IMT. 
He concluded in his study that adverse outcomes in patients with increased 
IASBPD might be linked to atherosclerosis. 
2. AGE: 
Persons with age group 45 – 70 years were included in this study.   Mean 
age of this study group was 56.16 years. 
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Correlation of IASBPD with age 
In this study, there was a statistically significant positive correlation   
between interarm systolic BP difference and age (p < 0.05) 
Kimura et al, 2004 reported absolute IASBPD was significantly and 
positively correlated with age. MA et Al, 2016 documented age was 
significantly associated with IASBPD increasing. The present study was 
concordant with the above studies. Grossman et al, 2014 reported age was not 
associated with IASBPD. 
Correlation of CIMT with age 
The present study showed statistically significant positive correlation 
between CIMT and age (p< 0.05) and mean CIMT values were high in the age 
group of 55-65 years. Paul et al 2012 reported high mean CIMT values in the 
age group of 61-80 years. 
Manuel A. Gómez-Marcos et al 2012 and Paul et al 2012 documented a 
significant positive correlation of CIMT with age. Abiodun et al.2018, reported 
there was a significant gradual increase in average CIMT with age in the study 
participants (r=0.827). 
3. BODY MASS INDEX: 
Mean BMI of the study group was 24.61 kg/m2. 
Correlation of IASBPD with BMI 
In this study there was a statistically significant positive correlation                
(p < 0.05) of IASBPD with BMI. 
77 
 
Tokitsu et al, 2015 reported that BMI was significantly higher in those 
with high IASBPD. Manuel A. Gómez-Marcos et al 2012 showed that IASBPD 
was significantly correlated with BMI which was in accordance to the present 
study. Grossman et al, 2014 reported that BMI was not associated with 
IASBPD. 
Correlation of CIMT with BMI 
 
In this study, statistically significant positive correlation was observed 
between CIMT and BMI. 
The study results were concordant with the study conducted by Sameeah 
A.Rashid et al 2015, who showed a significant positive correlation between 
CIMT and BMI and more rapid change in IMT occured in the group with BMI 
values >30 kg/m2. 
Abiodun et al. 2018 reported that BMI showed a strong positive 
correlation with average CIMT(r=0.503,p< 0.05). 
Umeh et al, 2014 reported a weak positive correlation between BMI and 
CIMT on both sides in their study subjects, which was not statistically significant 
(r 5.252; P 5.070). Ibinaiye et al, 2015 found that BMI had a negative 
correlation with CIMT (r 5–.23; P 5.020). 
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4. SEX: 
Among study population of 100, 64 cases were males and 36 were 
females. 22 males and 9 females had IASBPD ≥ 10. Mean IASBPD in females 
was 16.11mm Hg and in males it was12.77mm Hg. 
Association of sex with IASBPD 
In this study there was no association between sex and IASBPD  (p=0.33). 
Lane D et al 2002 and Kimura A et al’ 2004 have documented   gender was 
not a significant factor associated with a large interarm SBP difference. The 
present study results were consistent with the above study results. 
Ho-Ming Su et al,2012 documented female gender was an  independent 
risk factor for an interarm SBP difference of 10 mmHg or more. Tokitsuet 
al,2015 reported male sex was independently and significantly associated with 
the presence of  IASBPD. 
Association of sex with CIMT 
In this study there was no significant association between sex and CIMT 
(p value-0.789). 32 males and 17 females had CIMT ≥ 0.8. Mean CIMT in males 
was 0.88mm and in females was 0.84mm 
Ibinaiye et al, 2015 and Relwani PR et al 2017 documented gender 
difference in CIMT was not statistically significant. The present study showed 
similar results with above studies. 
Paul et al.: 2012, documented sex was significantly correlated with 
CIMT (p=0.001) and male sex had higher CIMT values than age matched female 
sex. 
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5.  TOTAL CHOLESTEROL 
In this study, mean total cholesterol was 186 mg/dl in the study group.  
About 23 patients had cholesterol values more than 200 mg/dl. 
Correlation of IASBPD with Total cholesterol 
In this study correlation between Interarm systolic BP difference and total   
cholesterol was positive and statistically significant (p < 0.05). 
Kimura et al, 2004 documented that absolute SBP difference was 
significantly and positively correlated with total cholesterol. Weinberg et al, 
2013 reported that patients with elevated interarm systolic BP difference had 
higher total cholesterol (212mg/dl). 
Correlation of CIMT with Total cholesterol 
In this study there was a significant positive correlation between CIMT 
and total cholesterol (p < 0.5). V. Mohan et al.1999 reported serum cholesterol 
level had a positive correlation with cIMT. Weingartner et al 2010 showed that 
CIMT was positively correlated with cholesterol (r = 0.24, P <0.0005) 
Sameeah A. Rashid et al 2015 reported that high serum  cholesterol 
showed significant correlation with CIMT. The present study results were 
consistent with above study results. 
 
  
 
 
 
 
 
 
 
 
 
CONCLUSION 
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CONCLUSION 
Present study showed that there was a statistically significant positive 
correlation between interarm systolic blood pressure difference and carotid 
intima media thickness in hypertensive patients with coronary artery disease and 
stroke. Carotid intima media thickness was an important risk marker for 
atherosclerosis. From above finding it was clear that increased interarm systolic 
BP difference was related to progression of atherosclerotic process and thereby 
led to future cardiovascular diseases. So early detection of IASBPD may be 
useful for preventing the progression of atherosclerosis and reducing 
cardiovascular mortality. 
The vast majority of patients with hypertension are managed in primary 
care and measurement of BP is the most common investigation performed in this 
setting. Failure to recognise a difference can lead to underestimation or under-
treatment of blood pressure. 
By recording blood pressure in both the arms during the first visit not only 
avoids under diagnosis of hypertension but also helps to stratify hypertensive 
patients at risk of future cardiovascular diseases. Identification of atherosclerosis 
in the arteries requires sophisticated imaging techniques and  is  not  routinely 
assessed  in  primary  care  and   also requires time,  equipment,  and  expertise. 
The IASBPD is a simple, economical and effective tool that can be used to 
screen patients for cardiovascular diseases at the primary health care system 
itself. 
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Detection of an interarm BP difference results in prompt consideration of 
further vascular assessment and aggressive management along secondary 
prevention guidelines and there by helps to prevent adverse outcomes. 
As recording of inter-arm systolic BP difference is a simple, reproducible, 
and inexpensive  method  it can be recommended in all clinical settings for  
stratifying  the hypertensive patients at risk of  future cardiovascular disease. 
 
LIMITATIONS 
 
 
 As the study was conducted in a small population, further studies with 
large sample size need to be done to strengthen the results. 
 In this study only carotid atherosclerosis was assessed by carotid Doppler. 
Further studies with investigations directed to assess the severity of 
coronary and cerebral atherosclerosis such as coronary and MR 
angiography need to be done. 
 Further prospective studies are needed to assess the prognostic value of 
IASBPD in patients with cardiovascular diseases. 
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CORRELATION BETWEEN INTERARM SYSTOLIC BLOOD 
PRESSURE    DIFFERENCE AND CAROTID INTIMA MEDIA 
THICKNESS IN PATIENTS WITH CORONARY ARTERY 
DISEASE AND STROKE 
PROFORMA 
 
Name:                                                     Age in years:                        Sex: M/F              
Occupation:                                             OP/ IP no:   
Address:  
H/O PRESENTING COMPLAINTS:                                                   
H/O   chest pain –                                                                                 YES/NO 
  site, any radiation, aggravated  by exertion 
H/O   shortness of breath on exertion                                                  YES/NO 
H/O   palpitation                                                                                  YES/NO                                    
H/O   puffiness of face                                                                        YES/NO   
H/O   edema of  legs                                                                            YES/NO       
H/O  giddiness/loss of consciousness                                                  YES/NO 
H/O   weakness in arms or legs                                                            YES/NO                                   
H/O  difficulty in swallowing                                                               YES/NO 
H/O  speech disturbance                                                                       YES/NO      
H/O   transient loss of vision                                                                 YES/NO                                                             
H/O   drooling of saliva                                                                         YES/NO   
H/O deviation of angle of mouth                                                           YES/NO   
H/O   nasal bleed                                                                                   YES/NO   
H/O   decreased urine output                                                                 YES/NO   
H/O  pain in the legs while walking                                                      YES/NO        
     
PAST HISTORY: 
H/O  similar episodes before                                                                 YES/NO    
H/O Hypertension,                                                                                 YES/NO    
H/O DiabetesMellitus/Chronickidneydisease                                        YES/NO                          
H/O Ischemic Heart Disease                                                                YES/NO    
H/O Transient Ischemic Attack                                                             YES/NO                                                              
H/O Stroke                                                                                             YES/NO                                                                                             
 H/O peripheral vascular disease                                                            YES/NO         
 
PERSONAL HISTORY: 
Dietary habits                                                                                        VEG/NONVEG 
H/O smoking                                                                                         YES/NO                 
H/O alcohol intake                                                                                YES/NO           
       
FAMILY HISTORY: 
H/O Hypertension/ Diabetes mellitus                                               YES/NO                 
Coronary artery disease/ Stroke/ Kidney disease 
 
GENERAL EXAMINATION: 
Consciousness                                     Orientation                           Pallor    
Cyanosis                                               Icterus                                 Clubbing   
Pedal edema   
Pulse rate :                 /minute                Rhythm;                            Volume 
Respiratory rate:        /minute                Temperature:         0F 
 
 
 
 
Recording of Interarm systolic blood pressure difference 
Blood pressure in mm/Hg :               Right arm                              Left arm 
1. 
2. 
3. 
Average: 
Absolute Inter arm BP difference:     Systolic BP                            Diastolic BP    
                                                           (|Right-Left|)                         (|Right-Left|) 
ANTHROPOMETRIC MEASUREMENTS: 
Height (cm):                                  Weight (kg):                                 BMI (kg/m2): 
 
SYSTEMIC  EXAMINATION: 
Cardiovascular system: 
Respiratory system: 
Abdomen: 
Central nervous system:  
 
INVESTIGATIONS: 
Carotid Doppler ultrasound  
Fasting & Postprandial Blood sugar                        
 Blood urea:                    
 Serum creatinine: 
 Lipid profile:                                                                
 ECG 
மருத்துவ பரிச ோதனைமுனைகனைப் பற்ைி மருத்துவரிடம் 
ததரிந்து தகோண்சடன்.  இதனை சமற்தகோள்ை நோன் முழுமைதுடன் 
 ம்மதிக்கிசைன்.    
MASTER CHART FOR STUDY POPULATION 
 
Sl.no. Name 
Age 
( yrs) 
Sex 
Ht 
(cms) 
Wt 
(kg) 
BMI 
(kg/m2) 
PR 
/min 
RR 
/min 
BP 
(mmHg) 
IASBPD 
(mmHg) 
CIMT 
(mm) 
Total 
cholesterol 
(mg/dl) 
1. Krishnan 58 M 167 69 24.9 84 20 120/76 1 0.72 167 
2 Kamatchi 61 F 165 74 27.4 76 18 154/91 5 0.8 182 
3 Chinnasamy 54 M 169 86 30.3 82 22 116/83 4 0.76 202 
4 Ramayee 55 F 163 65 24.7 78 18 148/86 10 0.99 196 
5 Sekaran 57 M 167 74 26.8 80 18 146/87 13 1.32 226 
6 Murugan 61 M 169 66 23.2 74 22 112/78 3 0.82 195 
7 Palanisamy 45 M 171 74 25.6 82 18 123/86 8 0.67 164 
8 Sarasu 57 F 154 58 24.7 72 20 120/78 5 0.87 173 
9 Sivakumar 63 M 163 69 26.1 82 20 136/78 11 0.99 196 
10 Palani 68 M 174 68 22.5 68 20 109/73 6 0.93 157 
11 Pappathy 58 F 162 74 28.4 92 22 118/72 4 0.71 182 
12 Jakir Hussain 59 M 173 78 26.1 98 20 98/79 5 0.66 178 
13 Petchikalai 55 M 164 65 24.4 78 18 120/76 4 0.81 188 
14 Vasantha 49 F 164 67 25.1 82 20 144/85 8 0.69 201 
15 Perumal 52 M 167 58 20.8 88 22 102/84 5 0.87 175 
16 Kandasamy 61 M 159 64 25.6 76 20 138/89 13 1.1 182 
17 Pandiarajan 58 M 165 78 29 84 18 142/86 12 1.01 204 
18 Lakshmi 67 F 157 63 25.6 78 20 110/70 9 0.75 184 
19 Karuppanan 56 M 166 77 28.2 92 20 98/64 7 0.65 195 
20 Chinnapandi 65 M 177 76 24.3 88 22 128/83 11 1.12 211 
Sl.no. Name 
Age 
( yrs) 
Sex 
Ht 
(cms) 
Wt 
(kg) 
BMI 
(kg/m2) 
PR 
/min 
RR 
/min 
BP 
(mmHg) 
IASBPD 
(mmHg) 
CIMT 
(mm) 
Total 
cholesterol 
(mg/dl) 
21 Aanandi 52 F 161 59 22.8 74 18 120/70 5 0.86 169 
22 Shanmugam 58 M 156 59 24.5 82 20 136/81 10 0.97 196 
23 Saraswathi 68 F 154 58 24.5 78 22 130/70 6 0.73 172 
24 Gajalakshmi 58 F 161 55 21.6 82 18 122/78 3 0.7 183 
25 Vijaya 52 F 158 56 22.4 98 22 90/60 1 0.67 188 
26 Chinnaya 65 M 166 65 23.8 84 18 142/87 12 1.12 182 
27 Devi 54 F 169 86 30.2 88 20 113/72 9 0.84 211 
28 Thavapandi 59 M 167 73 26.4 78 18 128/85 16 1.4 209 
29 Sathyamoorthy 66 M 168 68 24.3 84 20 126/70 8 0.88 185 
30 Meyyammai 52 F 169 55 19.5 92 20 110/81 8 0.67 172 
31 Jeyachandran 57 M 175 64 20.9 81 20 108/74 4 0.78 176 
32 Kaliammal 67 F 156 62 25.7 92 20 116/85 7 0.9 182 
33 Muruganantham 62 M 168 74 26.3 84 18 151/73 14 1.19 204 
34 Kannan 51 M 167 61 21.9 96 22 120/81 6 0.66 187 
35 Nagoorammal 55 F 160 61 24.2 82 18 128/77 11 1.04 181 
36 Sadayandi 52 M 168 60 21.3 78 22 106/71 2 0.62 172 
37 Sundari 56 F 159 66 26.1 82 20 121/75 4 0.72 188 
38 Aandavar 56 M 171 69 23.9 86 18 111/74 11 0.98 202 
39 Selvaraj 51 M 162 58 22.1 92 20 98/71 2 0.61 192 
40 vellaiammal 66 F 169 76 26.7 84 20 141/92 17 1.31 218 
Sl.no. Name 
Age 
( yrs) 
Sex 
Ht 
(cms) 
Wt 
(kg) 
BMI 
(kg/m2) 
PR 
/min 
RR 
/min 
BP 
(mmHg) 
IASBPD 
(mmHg) 
CIMT 
(mm) 
Total 
cholesterol 
(mg/dl) 
41 Panchu 48 F 154 46 19.4 74 18 112/73 3 0.69 168 
42 Murugeswari 53 F 156 57 23.5 81 20 110/80 3 0.62 177 
43 Marimuthu 48 M 172 79 23.7 85 22 134/72 10 0.76 191 
44 Soundarapandian 55 M 168 62 28.2 74 18 121/82 5 0.81 203 
45 Veerasamy 52 M 159 55 21.8 96 20 97/72 4 0.69 183 
46 RaniS 59 F 162 64 24.6 84 22 127/78 13 1.06 187 
47 Balu 53 M 158 56 22.6 92 20 111/78 3 0.71 179 
48 Rakkammal 46 F 165 59 21.8 76 18 102/68 4 0.72 182 
49 Muniyandi 65 M 168 74 26.4 82 20 151/94 16 1.28 216 
50 Kannan 47 M 170 62 21.5 88 20 123/81 8 0.62 187 
51 Subbulakshmi 56 F 162 58 22.1 82 20 131/80 7 0.78 173 
52 Thavamani 64 M 175 67 22.2 70 18 114/77 4 0.64 158 
53 Manikandan 48 M 177 77 24.7 88 20 138/76 12 1.04 185 
54 Gokila 52 F 159 50 19.8 76 22 106/78 1 0.71 161 
55 Pethammal 53 F 152 56 24.2 81 20 141/84 3 0.66 171 
56 Gomathinayagam 65 M 165 76 28 78 22 129/86 18 1.41 218 
57 Pandi 53 M 174 64 21.1 90 18 114/88 2 0.6 184 
58 Parimalar 59 F 167 71 25.5 82 20 152/95 16 1.18 218 
59 Rasu 47 M 164 62 23.3 81 20 139/88 5 0.76 212 
60 Peter joseph 50 M 176 65 21 77 18 123/81 1 0.64 182 
Sl.no. Name 
Age 
( yrs) 
Sex 
Ht 
(cms) 
Wt 
(kg) 
BMI 
(kg/m2) 
PR 
/min 
RR 
/min 
BP 
(mmHg) 
IASBPD 
(mmHg) 
CIMT 
(mm) 
Total 
cholesterol 
(mg/dl) 
61 Balamurugan 54 M 167 78 28.1 82 20 148/86 11 0.91 204 
62 Rameshwari 48 F 159 60 24 75 22 120/77 3 0.65 166 
63 Raghavan 51 M 170 75 26.1 86 20 138/72 8 0.9 221 
64 Alagumalai 49 M 167 59 21.2 80 18 144/91 4 0.64 156 
65 Nagarani 62 F 157 59 24.2 76 20 146/92 14 1.01 185 
66 Malarkodi 57 F 159 60 24.1 74 18 110/72 2 0.71 177 
67 Kulanthaisamy 51 M 162 60 23 91 20 121/84 2 0.69 194 
68 Thirumurugan 58 M 160 62 24.2 81 18 120/71 4 0.84 172 
69 Sadayandi 54 M 168 73 25.9 86 20 129/88 11 0.92 182 
70 Kamala 52 F 162 74 28.4 79 22 158/96 6 0.88 164 
71 Kilikomban 50 M 158 55 22 92 20 127/82 3 0.62 182 
72 Vinayagamoorthy 58 M 172 80 27.2 72 18 105/76 5 0.69 172 
73 Bharadan 68 M 161 68 26.4 84 20 155/82 17 1.37 219 
74 Angumani 51 F 169 60 21 78 20 141/86 3 0.61 182 
75 Syed Ibrahim 58 M 172 69 23.3 89 22 98/65 4 0.73 175 
76 Guruvammal 62 F 161 65 25.3 78 20 165/82 12 1.23 191 
77 Mohammed Ali 65 M 159 64 25.5 91 20 126/78 3 0.81 177 
78 Parthiban 55 M 166 72 26.2 76 18 129/82 14 1.3 209 
79 Nagarathinam 54 F 160 65 25.4 78 20 104/66 4 0.66 163 
80 Arjunan 49 M 179 71 22.3 82 20 111/82 2 0.73 179 
Sl.no. Name 
Age 
( yrs) 
Sex 
Ht 
(cms) 
Wt 
(kg) 
BMI 
(kg/m2) 
PR 
/min 
RR 
/min 
BP 
(mmHg) 
IASBPD 
(mmHg) 
CIMT 
(mm) 
Total 
cholesterol 
(mg/dl) 
81 Soundarajan 57 M 158 64 25.7 81 20 155/92 12 1.1 182 
82 Mariselvi 51 F 171 69 23.9 78 18 113/82 6 0.92 175 
83 Kamarajan 49 M 164 67 25.2 84 22 130/71 4 0.66 169 
84 Veluthai 64 F 168 87 31 78 20 124/83 19 1.38 214 
85 Karuppanan 55 M 163 65 24.7 76 18 116/74 2 0.63 171 
86 Mayandi 52 M 168 71 25.4 78 18 126/88 4 0.74 177 
87 Tamilselvan 60 M 171 75 25.9 91 20 137/90 7 0.87 192 
88 Arumugam 70 M 162 67 25.8 76 18 120/78 9 0.97 187 
89 Chandrasekar 48 M 163 59 22.3 88 20 109/66 3 0.61 184 
90 Annalakshmi 62 F 156 60 24.7 80 18 138/90 15 1.18 192 
91 Arokiasamy 65 M 164 63 23.6 77 20 143/89 12 0.92 201 
92 Ayyanar 56 M 162 66 25.3 74 18 114/80 1 0.65 178 
93 Veeramani 53 M 172 76 25.7 83 20 136/74 2 0.7 182 
94 Kalaiselvi 58 F 156 63 26.2 92 20 123/78 4 0.82 230 
95 Maruthamuthu 46 M 159 76 30.1 79 18 109/67 8 0.78 178 
96 Thomas 54 M 168 62 22.1 80 20 117/85 5 0.8 183 
97 Shanmugavel 63 M 163 67 25.5 78 20 164/98 14 1.03 208 
98 Annadurai 51 M 175 74 24.3 82 20 129/81 11 0.79 188 
99 Veeralakshmi 52 F 152 56 24.3 69 18 106/73 6 0.63 162 
100 Ganesan 55 M 178 87 27.6 82 20 134/85 6 0.76 175 
ABBREVIATIONS 
 
  
Sl.No. ABBREVIATION EXPANSION 
1. CVD Cardiovascular disease 
2. JNC Joint national committee 
3. CAD Coronary artery disease 
4. CHD Coronary heart disease 
5. IASBPD Interarm systolic bloodpressure difference 
6. CIMT Carotid intima media thickness 
7. PWV Pulse wave velocity 
8 ABI Ankle- brachial index 
9. ASE American Society of Echocardiography 
10. RAAS Renin-angiotensin-aldosterone system 
11. ISH Isolated systolic hypertension 
12. CHF Congestive heart failure 
13. PAD Peripheral arterial disease 
14. ACCF American College of Cardiology Foundation 
15. AHA American Heart Association 
16. CRP C-reactive protein 
17. ESC European  society of cardiology 
18. LVH Left ventricular hypertrophy 
19. LVMI Left ventricular mass index 
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